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Abstract
This thesis evaluated the functional and psychological outcomes in older adults with a
periprosthetic femoral fracture (PPF) after total hip arthroplasty. The first study was a retrospective
chart review of 130 people who had PPF surgery to evaluate the functional and psychological
outcomes and mortality rate at one-year post-PPF surgery. The second study assessed falls,
mobility, balance, and lower extremity strength in ten people at 6-months to 4-years after PPF
surgery. In Study 1, people had low scores on function and psychological well-being and the oneyear mortality was 15.4%. Participants in Study 2 demonstrated slower gait, reduced mobility,
balance and leg strength compared to age and sex-matched normative values, social isolation, a
lack of falls awareness and a falls occurrence of 50.0%. These indicate that the evaluation of
rehabilitation protocols for functional and psychological recovery is warranted to achieve better
outcomes in this population.
Keywords: Periprosthetic femoral fracture, total hip arthroplasty, outcome, mortality rate, falls,
older adults.
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Summary for Lay Audience
A fall in an older adult after hip replacement surgery can cause a fracture around the new hip.
These fractures usually require surgery to fix and few studies have evaluated the physical and
mental health of patients after successful repair of the fracture. Importantly, no research has looked
at new falls and awareness of falls prevention after the repair surgery. The purpose of these two
studies was to increase our understanding of the physical and mental health outcomes of older
adults after their fracture repair surgery. In the first study, medical charts of 130 people were
reviewed to evaluate the physical and mental health status and the number of people who died at
one-year after the surgery for the fracture. In the second study, ten people with this kind of fracture
were assessed for falls occurrences and knowledge of falls. In addition, walking speed, mobility,
balance, and leg strength were evaluated at 6-months to 4-years after the surgery for the fracture.
We found poor physical and mental health at one-year after their repair surgery. We found 15.4%
of people who had the surgery to repair the fracture had died in the first year. People in Study 2
walked slower and had reduced leg strength, balance, and mobility compared to healthy older
adults and reported social isolation after their repair surgery. Half of the people fell after their
repair surgery for the fracture and lacked the knowledge to prevent falls. Our findings demonstrate
that the evaluation of the rehabilitation protocols is needed to ensure better mental and physical
health status in older adults after this fracture.
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Chapter 1: LITERATURE REVIEW
1.1 Introduction
Osteoarthritis (OA) is a chronic degenerative disease affecting the articular cartilage, peri-articular
structures and subchondral bone.1,2 In older adults, OA is the leading cause of lower extremity
disability and is seen most often in the weight-bearing lower limb joints including the hip joint. 1,3
Conservative approaches such as weight reduction, analgesics, and lifestyle modification are
introduced first to reduce the symptoms of OA.4,5 In advanced stages of hip OA, if conservative
management fails then the standard of care for surgical intervention is a total hip arthroplasty
(THA).4 After THA, most people report reduced pain symptoms and an improved quality of life
(QoL) partly due to a regained ability to return to the activities they enjoy. 6,7 However, functional
deficits in lower extremity strength, balance and gait are present after THA which can result in
higher falls risk among older adults compared to healthy adults. 8–11
Falls after THA can have devastating consequences, especially if a fracture occurs around the
implant.12 This type of fracture is called a periprosthetic femoral fracture (PPF).12 Multiple
predisposing risk factors have been identified for PPF including older age, female sex,
osteoporosis, previous trauma, inflammatory arthritis, previous revision surgeries, and type of the
implant, among others.13–15 The majority of PPFs require surgical intervention such as a revision
THA.16 Undergoing revision surgery due to PPF after THA has been found to result in significantly
decreased physical function and an increased mortality risk in older adults. 17–21 Current published
studies on PPF after THA mainly focus on the predisposing risk factors, and the classification and
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surgical management of these fractures.22–24 Very little is known about the consequences, both
physical and psychological, of PPF after THA.

1.2 Osteoarthritis of the hip
Osteoarthritis (OA) is a common chronic degenerative joint disease in older adults (> 60 years). 1,2
OA can affect multiple joint tissues including, articular cartilage, synovium, ligaments,
periarticular muscles, subchondral bone and meniscus where present. 25,26 As a result of OA, a joint
can demonstrate degradation of articular cartilage, formation of new bone at the joint margins,
changes to subchondral bone, and inflammation of the synovium. 26–28 The primary symptoms of
OA are pain, joint stiffness, reduced joint movement and joint swelling. 28,29 Weight-bearing joints
are more likely to be affected by OA, such as the hip and knee. 1,3
For OA of the hip, the joint pain is typically localized to the areas of the groin, anterior or lateral
thigh and buttock areas.30 In the early stages of the disease, the joint pain is usually exacerbated
by activity and relieved by rest.31 As the disease progresses, the pain can be severe, frequent and
unpredictable and not relieved by resting.31 Reduced muscle volume and strength in the affected
lower limb compared to the contralateral side are common in people with advanced stages of hip
OA.32,33 The muscle weakness can also occur during the earlier stages of the disease. 34 Gait
impairments such as reduced walking speed and step length, and decreased hip joint excursion are
also present in people with hip OA compared to healthy adults. 35,36 These deficits and severe
symptoms of hip OA restrict physical activity and participation, thus limiting daily life activities
and adversely impacting the QoL.28,37
1.2.1

Epidemiology of OA
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In older adults (> 60 years), about 9.6% of men and 18.0% of women have OA globally. 38 In the
general Canadian population the prevalence of OA is approximately 10.0%. 39,40 The prevalence of
hip OA among the Canadian population aged 65 or older is 44% .41 The prevalence of OA increases
with age from 1.6% among Canadians aged 30 - 39 years to 35.1% in those 80 years or older.41,42
In Canada, OA is on the rise and expected to increase by 64% from 3.6 million in 2010 to almost
6.6 million individuals affected in 2031.43
OA is associated with a substantial economic burden for both the health-care system and the
individuals living with the disease, a burden that will increase as the rate of OA increases. 43–45 The
annual medical expenditure associated with OA for an average Canadian adult is incurred through
both direct (hospitalizations, physician visits, prescription medications, rehabilitation and
caregiver costs etc.) and indirect (unemployment, missed days of work and reduced productivity)
costs.43,44 The indirect cost makes up the majority of the annual medical expenditure with an
average indirect cost of CAD $12,990 in contrast to CAD $2,300 for direct cost. 44 It is predicted
that the total annual costs associated with OA in Canada will rise in coming years, from CAD $2.9
billion in 2010 to CAD $7.6 billion by 2031.43
1.2.2

Risk factors for the development of OA

Risk factors for developing OA can broadly be divided into local and systemic factors. 1,3,46,47 Local
factors are biomechanical in nature and affect the application of forces to a joint including joint
malalignment, trauma and joint structural abnormalities. 3,46,47 Several systemic risk factors have
also been identified including age, sex, obesity and genetics. 46,47 These systemic factors are
believed to increase the risk of OA by increasing the susceptibility for joint injury. 1,2,48
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The most prominent risk factor for the development of OA is increasing age. 1,46 Age-related
changes such as reduced muscle strength, loss of proprioception, sarcopenia and increased bone
turnover, play an important role in the development of OA in older adults. 49–51 Obesity, defined as
a body mass index (BMI) ≥ 30 kg/m2, is another prominent risk factor for the development of
OA.52,53 Jiang et al. reported that each additional increase of 5 units in BMI beyond the normal
value of 24.9 resulted in an 11% increase in the risk of developing hip OA. 54 However, there are
contradictory findings on the association between high BMI and hip OA. 2,47,53 Additionally,
women have a greater risk of developing hip OA than men.1,2 The increased risk for women is
most remarkable after menopause.55,56 The most common theory for the higher risk of OA among
women is due to hormonal differences, yet there has been limited evidence to support these
claims.1,3 There is, however, increasing evidence of a genetic component in the development of
OA.57–59 Twin studies have determined that the influence of genetic factors in the development of
hip OA is approximately 70%.60 Genetic variations may also play a role in disease
susceptibility.58,59 The genetic heritability, which refers to variance in a trait, of hip OA is
approximately 60%.59
Prolonged periods of repetitive and intense joint use in certain occupations have been shown to
increase the risk of OA.4,61 Occupations such as farming, construction work and those including
prolonged standing, heavy lifting and climbing stairs are associated with the development of hip
OA.1,61–64 Prior hip injuries incurred from trauma and participation in contact sports have
quadrupled the risk of hip OA.65 The risk of developing hip OA is further exacerbated by bony
abnormalities such as developmental dysplasia of the hip, femoral acetabular impingement and
acetabular dysplasia.66–69 While there has been limited evidence of the association between joint
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malalignment and onset of OA, there are strong indications that joint malalignment plays a role in
disease progression.3,46,47
1.2.3

Diagnosis of OA

Diagnosis of hip OA usually involves reviewing medical history, focused clinical examinations
and radiographic evidence.70,71 After reviewing the medical history and clinical symptoms, a
focused clinical examination is performed to determine the source of the pain and to rule out other
potential diseases such as spine pathology and trochanteric bursitis. 70–72 The clinical examination
includes a thorough evaluation of hip range of motion and hip-specific testing (e.g., tenderness at
the hip, comparing the leg length between affected and healthy limbs) along with gait
assessments.72
OA is primarily a clinical diagnosis; however, plain radiography of the hip joint is often performed
to confirm the diagnosis and determine the progression of the disease. 4,5,70 The common
radiographic findings of hip OA include joint space narrowing, new bone formation on the joint
margins, hardening of bone and formation of cysts below the cartilage surface. 71,73 These
radiographic structural changes due to OA are often graded using a standard grading system, such
as the Kallgren and Lawrence grade system, to determine the severity of disease and to guide the
treatment options.72,74,75 However, there is discordance between the clinical presentations, severity
of the symptoms and the radiographic findings in the case of hip OA.76–78 Only 20.7% to 23.8%
of patients with radiographic hip OA report frequent hip pain, whereas only 9.1% to 15.6% of
those with frequent hip pain show evidence of OA through imaging. 78 These findings demonstrate
that the radiological findings do not always correspond with the presence and severity of hip pain
in the case of hip OA.
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1.2.4

Treatment of hip OA

The aim of the management of hip OA is to reduce joint pain, improve physical function and
overall QoL.79 There are several treatment options for managing the symptoms of hip OA.
Lifestyle modifications (e.g., weight reduction and exercise) in conjunction with pharmacological
therapies are considered first line treatments.4,5 A wide range of oral analgesics, such as
acetaminophen, NSAIDs and opioids, are commonly used to manage pain associated with hip OA.
5,65,70

Intra-articular corticosteroid injections are also considered when the joint pain is

nonresponsive to oral analgesics.5 In mild to moderate hip OA, intra-articular administration of
hyaluronic acid, a glycosaminoglycan found in synovial fluid, is another widely used treatment
option to reduce the pain and improve the functional disability. 80 Hyaluronic acid injections have
also been found superior to platelet rich plasma in relieving the pain and improving the functional
status in people with mild to moderate hip OA.80 Autologous (involving one individual as both
donor and recipient) bone marrow aspirate concentrate (BMC) containing mesenchymal stem
cells, usually collected from the iliac crest, is an emerging treatment modality for the early stages
of hip OA.81,82 A recent cohort study involving 19 patients found that in 63.2% of people with
early stages of hip or knee OA, intra-articular injections of BMC showed a significant
improvement in the symptoms within the first 6 months of the treatment. 82 While these treatment
options may relieve the joint pain and reduce disability in mild to moderate hip OA, severe hip
OA may require surgical interventions such as total hip arthroplasty. 4

1.3 Total hip arthroplasty
Total hip arthroplasty (THA) is a common orthopaedic procedure in older adults. 83 The surgical
procedure of THA involves replacing the diseased acetabular cartilage, head and proximal neck of
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the femur, and subchondral bone with a prosthesis. Currently, greater than 1 million THAs are
performed worldwide each year.84 Canadian patients underwent 58,492 THAs in 2017 - 2018, with
the number increasing by 17.4% within the last 5 years. 83 For the average Canadian, a THA
accounts for substantial annual health-care costs amounting to CAD $11,500, excluding physician
and rehabilitation expenses.83
THA is indicated for several conditions of the hip joint, the most common of these being hip
OA.65,83,84 Conditions such as femoral neck fracture, avascular necrosis, post traumatic arthritis,
dysplasia and inflammatory arthritis are also indications for THA; however, hip OA accounts for
81.3% of all THA procedures.65,83,84 THA is typically performed in the advanced stages of hip OA;
yet, the procedure may also be performed earlier in the disease progression based on the functional
decline associated with hip OA.85 THA is considered an effective procedure in alleviating the pain
and improving the functional ability and health-related quality of life (QoL). 6,86 After THA, over
90% of people experience significant relief of pain and increased functional ability within 1-2
years of surgery, with the most marked improvements occurring during the first three to six
months.6,7 However, preoperative hip muscle weakness and gait impairments in the affected limb
are not fully recovered after THA.8,87,88 Rasch et al. reported that all preoperative hip muscle
(flexors, extensors, and adductors) deficits in the affected limb showed a significant improvement
2-years after THA except for hip abductors deficits, which remained similar. 87 Reduced walking
speed and hip range of movement, and decreased peak abduction, extension and external rotation
moments during gait-related daily life activities also persist in people after THA compared to
healthy older adults.88
1.3.1

The modes of failure of THA
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THA may last for 25 years; however, it may fail earlier requiring revision surgery, referred to as
revision THA (rTHA).89,90 The rTHA is defined as the replacement of one or more damaged
components of the THA.84 Due to an increasing aging population, the number of rTHA surgeries
performed in Canada has increased over time.83 In Canada, 4,822 revision hip replacements were
undertaken in 2017 - 2018, representing 8.2% of all THAs with an increase of 2.2% over the
previous five years.83 While the rTHA represents a small proportion of total annual THAs, the
annual cost associated with the rTHA is higher than the primary THA (pTHA). The cost of rTHA
is approximately CAD $18,600, a 63% increased from pTHA. 83
Failure of the pTHA can happen for several reasons. 89,91 The most common reasons for the failure
of pTHA include aseptic loosening of the femoral or acetabular components, periprosthetic
infection (infection around the prosthesis), dislocation, and periprosthetic fracture around the
femoral or acetabular component.90–92 The modes of the failure are dependent on several factors
including, age, obesity, surgical approach, and implant-related factors (e.g., cemented or
cementless, modularity).90,93,94 Obese people who undergo an uncemented pTHA are at a higher
risk of failure of the pTHA than non-obese people. 93,95 Periprosthetic fractures have been reported
as a leading cause of failure at 29.6% of pTHAs among Canadian females aged 65 - 74, whereas
instability (24.4%) has been found as the most common reason for the failure of pTHA in those
younger than 55 years.83

1.4 Falls in older adults after THA
Although THA is a successful procedure in improving the pain and health-related QoL of people
with hip OA, decreased abductor muscle strength and gait imbalance are common after THA. 8–10
These functional deficits are common after pTHA and are exacerbated after rTHA, which may
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contribute to a higher risk of falls in older adults with THA.8,11 Falls are a major public health
concern among Canadian older adults (> 65 years).96 Approximately 20% to 30% of communitydwelling Canadian adults aged > 65 years experience at least one fall in a year, of which 61% are
women and 39% are men.97,98 The incidence of falls increases with age, with 17% of Canadians
aged between 65 - 67 years experiencing falls compared to 27% in those aged 85 years or older. 97
The definition of falls differs among studies,99 the most commonly used definition of a fall is “an
unexpected event in which the participants come to rest on the ground, floor, or lower level”. 100
The risk factors associated with falls are multifactorial. 101 Falls in older adults occur as a result of
the interaction between personal (intrinsic) and environmental (extrinsic) factors. 101 The intrinsic
factors are attributed to personal aspects such as increasing age, age-related sarcopenia (loss of
muscle tissue), female gender, gait disorder, and cognitive impairment. 101–103 The extrinsic factors
are related to the surrounding environment, such as living alone, environmental hazards (e.g.,
slipping, uneven surfaces), use of walking aids, and medications. 101,103
In older adults, falls can have serious physical and psychological consequences and reduce their
QoL.104,105 Stel et al. found that 35.3% of older adults who have fallen within the last year reported
reduced functional status, and 15.2% reported decreased physical activities as a direct result of the
most recent falls.105 Falls in older adults can lead to serious injuries such as fracture, dislocation,
and head trauma.106 These injuries are leading causes of emergency hospitalizations among older
adults.104 Every year, 81% of injury-induced hospitalizations among Canadian people aged >65
years are due to falls, and one-third of them end up in long-term care facilities. 97,107 The hospital
admissions rate due to falls has increased by 9% within the last 3 years. 107 Accidental injuries are
the fifth leading cause of unintentional deaths among older adults after cardiovascular disease,
cancer, stroke and pulmonary disease, and two-thirds of these deaths are attributed to falls related
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injuries.103 Fear of falling (FOF), a common psychological consequence of falls may lead to
reduced confidence, increased dependency, depression, and social isolation among older adults. 108
Individuals who experience falls restrict their daily life activities due to fear of future falling,
leading to lower extremity muscle weakness, which can further increase the probability of future
falls in older adults.109 FOF is also a prevalent risk factor for older adults who have not sustained
a fall.109 More than one third of Canadian adults aged 65 years or older perceive a risk of falling
regardless of a previous history of falls.109
In older adults, the falls risk after THA is significant. Approximately 25% to 36% of people
experience at least one fall in the year following THA, which is comparable or slightly increased
over risk for community-dwelling older adults.12,106,110 In a recent meta-analysis, Lo et al. reported
a fall rate during the first few days after THA ranging from 0.8% to 2.7%, which increases
significantly during the 2-years post-THA which ranged from 3.14% to 51.8%. 111 Within our
research group, a previous study on falls after THA in adults aged 60 years or older had also found
a 21.5% falls prevalence within one-year after the surgery. 112 The higher fall risk after THA can
be influenced by advanced age, female gender, and preoperative history of falls, severe depressive
symptoms and comorbidities.111,113,114 The postoperative factors that are associated with the higher
risk of falls after THA include undergoing rTHA, gait imbalance, restricted hip range of motion
and prescription medications (e.g., antidepressants).99,111,115 Advanced age is the most frequently
reported risk factor for both in-patient and post-discharge falls after THA, with an additional 7%
increase in fall risk for each additional year beyond 65 years. 111

1.5

Periprosthetic femoral fracture after THA
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A fracture around the femoral implants in the THA, known as periprosthetic femoral fracture
(PPF), can be a serious adverse event.12 PPF can occur either during (intraoperative PPF) or after
(postoperative PPF) a THA.116 The intraoperative PPFs can be occult; however, in most cases they
are identified and managed during the THA procedure.23,116 The majority of intraoperative PPFs
(35% - 60%) are related to THA procedures from forceful preparation of the femur or placement
of the proximal femoral stem.117,118 Postoperative PPFs can occur within days to several years after
THA.119 In a Swedish joint registry-based prospective study, Lindahl et. al., found the time interval
between pTHA and the occurrence of PPF was 7.49 years, which was shorter in the case of rTHA
(3.9 years).119 A decrease in the time to PPF was observed as the number of rTHA increased, the
time was reduced to 3.8 years with two rTHAs and 2.3 years for 3 or more revision surgeries. 119
Approximately 70 - 81% of the postoperative PPFs in older adults occur as a result of low energy
traumas such as falls.119,120
Most people with a PPF after THA present with a sudden onset of thigh pain and difficulty in
ambulation.22,121 Diagnosis of PPF is made by obtaining a medical history, reviewing the previous
surgical history, and performing a thorough clinical examination.22 Plain radiography of the
affected femur and pelvis is performed to identify and locate the fracture, and associated implant
loosening.22 A suspicion of periprosthetic infection being present prior to sustaining a PPF
warrants further investigations such as blood profile or aspiration for cultures. 22,121 Diagnosis of
PPF is confirmed by history of trauma along with the presence of the radiolucent lines in the plain
radiography indicating a fracture around the implant. 22
1.5.1

The classification of PPF
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Several classification systems have been adopted to guide the treatment of PPF; however, the
Vancouver classification (Figure 1.1) is the most commonly used scale due to its significant intraand inter-observer reliability.24,122,123 The Vancouver classification system for PPF, developed by
Duncan and Masri in 1995, is based on the anatomic location and pattern of the fracture, prosthesis
stability, and the proportion of bone loss.24,121 The Vancouver classification of PPF is divided into
three categories, that include type A, type B and type C.124 The type A fracture is considered when
the fracture is around the trochanteric area of the femur, and this category is further subdivided
into AG (fracture around the greater trochanter) and AL (fracture of the lesser trochanter). The
type B fracture is associated with the fracture around the shaft of the femur. The type B fracture
has three subdivisions according to the fracture position and prosthesis stability, which are
B1(fracture with a stable prosthesis), B2 (fracture with loose prosthesis), and B3 (fracture with
loose prosthesis and bone loss). The type C fracture is considered when the fracture occurs beyond
the tip of the femoral stem.
Figure 1.1: The Vancouver classification of periprosthetic femoral fracture. (Adapted with
permission from © Marshall R A, Weaver M J, Sodickson A, et al. Periprosthetic femoral fractures
in the emergency department: What the orthopedic surgeon wants to know. RadioGraphics
2017;37: 1202 1217).
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1.5.2

Epidemiology of PPF

There is considerable variation in the reported incidence of PPF after THA among existing studies,
which is likely due to significant variation in the patient demographics, differences in the reported
length of the follow-up period after the THA, and the reporting of only PPFs that underwent
surgery.13,116 Additionally, to our knowledge, there is no epidemiological study of PPF after THA
that is based on a Canadian sample.
The incidence of PPF ranges from 0.07% to 11% for pTHA and increases after rTHA from 1.19%
to 18%.116,120,125,126 The incidence rate is greater in those who undergo uncemented femoral stems
(0.47% to 7.1% ) during THA compared to cemented femoral stems (0.07% - 3.5%). 116,118 The
cumulative incidence of PPF rises as the duration between the primary surgery and the occurrence
of PPF increases.118 In a large U.S. based cohort study of 32644 pTHAs over a 40-year period,
Abdel et al. reported the cumulative incidence rate of PPF increased from 0.4% at one-year to
3.5% at 20 years after pTHA.118 Although a small proportion of older adults sustain PPF after
THA, the number of PPFs is expected to increase in coming years. 127 The incidence of PPF is
expected to observe a 4.6% rise every 10 years over the next 30 years.127 This phenomenon will
likely be observed due to a significant increase in the aging population who have pTHAs and
rTHAs performed every year, combined with higher falls rates in older adults. 125,127
1.5.3

Risk factors of PPF

Several patient and surgery-related risk factors have been identified that are associated with the
risk of PPF after THA.13 Advanced age is the most common risk factor of PPF after THA, which
is likely due to age-related osteoporosis and increase in falls risk. 15,116,128,129 The risk of PPF is 4.4
fold higher among people aged 80 years or older compared to younger adults. 125,128 Although there
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are controversial findings regarding gender and its relation to PPF, 13,117 several studies have shown
that female gender is associated with a higher risk of PPF. 126,129 The risk of PPF is further
exacerbated in people with inflammatory arthropathies (e.g., OA, rheumatoid arthritis) and a prior
history of trauma, which is speculated to be due to the association of osteoporosis, comorbidities,
and steroid use in older adults.13–15 Undergoing a THA due to a hip fracture has also been found
to be associated with an increased risk of PPF. 15
Surgical techniques, including surgical approach of the pTHA have been found to be influencing
factors of PPF.24,130 Griffiths et al. showed, the risk of a type B fracture occurring within 6 weeks
of the index procedure was linked to the direct anterior surgical approach. 130 This is likely due to
inadequate exposure of the femur which may result in malpositioning of the femoral component
leading to reduced stability of the stem.130 In the case of both pTHA and rTHA, acetabular underreaming, forceful femoral insertion, and presence of osteolysis in the greater trochanter have been
reported to increase the risk of both intra- or postoperative PPFs. 24,125 The risk of PPF is further
influenced by the type of the femoral stem inserted during THA, with the greater risk of both intraand postoperative PPFs among uncemented femoral stems compared to cemented femoral
stems.14,117,118,131 A recent study found that 65% of type B2 fractures were associated with an
uncemented stem, whereas only 39% of type B2 fractures occurred in femurs with cemented
femoral stems.132 Additionally, prior history of ipsilateral lower extremity surgery has been found
to increase the risk of PPF by 3 times.16
1.5.4

Management of PPF

The management of PPF in older adults can be challenging for the surgeon due to the patient’s
advanced age, associated comorbidities and osteoporotic bone loss. 123 The aims of the
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management of PPF include prevention of fracture non-union, restoration of the bone alignment
and pre-PPF functional status, reducing the pain, and improving the QoL. 13,121,124 The treatment of
PPF is often guided by the classification of the fracture and patient characteristics such as age,
comorbidities, activity level, expectations, and the bone quality. 24
Un-displaced PPFs with stable implants PPF can be managed with conservative treatment such as
weight-bearing restriction and symptomatic pain management; however, displaced fractures with
unstable implants warrant surgical treatment. 16,124 The surgical options for managing PPF involve
rTHA and/or open reduction and internal fixation (ORIF) of the fracture, with or without bone
grafting depending on the type of the fracture.123 PPF with a stable implant can be managed with
ORIF without rTHA; however, PPF with a loose implant requires rTHA. 133 The fixation of the
PPF during the ORIF procedure is typically done using locking plate, cable plating, and wires,
either singly or in combination.123 While either of these techniques can be utilized to fix the
fracture, no surgical techniques have been found superior over others. 123
A type A fracture that is un-displaced and stable can be managed conservatively, whereas a
displaced type A fracture with or without proximal bone osteolysis may require surgical
management.16,121,133 The type B1 and C fractures can be managed with ORIF due to a stable
implant; however, the type B2 and B3 fractures require rTHA and ORIF as these fractures are
associated with loose implants.13,123,124 The combination of rTHA and ORIF for the management
of type B2 and B3 fractures has been found to be associated with a 98% union rate and only a 11%
failure rate requiring another revision surgery.123 Impaction bone grafting or insertion of a megaprosthesis (large prosthesis) may be indicated in cases of type B3 fractures due to the association
of inadequate bone stock that makes the surgical procedure challenging for these fractures. 123,133
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1.5.5

Outcomes of PPF in older adults

While PPF is a rare complication of THA, it can have unfavourable clinical outcomes in older
adults.17,18 Approximately 13% - 32% of PPFs are associated with postoperative complications
such as wound infection, re-fracture, dislocation, non-union and aseptic femoral loosening, which
subsequently require re-intervention.19,134–138 In a prospective study of 1049 cases spanning 22
years, Lindahl et al. reported that 61% of people with PPF who underwent rTHA experienced
variable degrees of pain after the surgery, and 23% of the people required re-operation. 119 Those
who required re-operation, 44.5% of them were re-operated within 12 months postoperatively. 119
The re-operation rate after surgical treatment of PPF is higher among the people who undergo
ORIF without rTHA than the people with rTHA.19 The majority of the people who undergo
surgical management for PPF suffer from significant pain, reduced mobility, worse hip function
and difficulty in returning back to pre-PPF functional status even after achieving fracture
union.17,19–21 A previous history of rTHA prior to sustaining a PPF is associated with significant
impaired function compared to PPF after pTHA.19
The mortality rate among people with PPF is significantly high, with the cumulative mortality rate
ranging from 21% - 46%, and 11% to 17% of deaths occurring during the first postoperative
year.18,20,21,138,139 The majority of the deaths after PPF occurs within 2 weeks to 6 months from
their surgery for PPF.21,140 Managing PPF by ORIF without rTHA has a higher mortality rate than
PPFs that are treated with rTHA.18 Bhattacharyya et al. found the mortality rate among people with
type B PPF who underwent ORIF without rTHA was 33% compared to people who had rTHA
(12%) to fix the fracture, which is likely due to earlier return to weight-bearing status after rTHA. 18
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The mortality risk after PPF is further increased in people with comorbid orthopaedic
conditions.141

1.6 Summary
Hip OA is the most common degenerative lower limb arthritis in older adults. A total hip
arthroplasty (THA) is typically performed in the advanced stages of hip OA once conservative
management has been exhausted. Total hip arthroplasty is an effective procedure in reducing pain,
improving physical function and health-related QoL in older adults with hip OA. Despite being
considered a successful procedure, gait imbalance and reduced lower extremity abductor muscle
strength are common after THA. These functional deficits along with advanced age result in an
increased falls risk after THA in older adults. Falls after THA can lead to severe injuries in older
adults such as PPF.
The majority of PPFs after THA require revision surgery to fix the fracture and restore the prePPF functional status. The management of PPF is often challenging for the orthopaedic surgeon
due to the occurrence of PPF at an advanced age and poor bone stock surrounding the fracture.
Despite achieving fracture union after the appropriate surgical management, PPF is associated with
a high rate of surgical complications and reoperation rates. Previous studies on the outcome of PPF
have mainly focused on the surgical complications and mortality rate. Very few studies have
evaluated functional and psychological consequences and overall QoL after PPF in the same cohort
of older adults. Given the advanced age and the occurrence of PPF due to falls, older adults may
remain vulnerable to future falls risk after sustaining a PPF. Falls risk and fear of falling have not
been examined in people after sustaining PPF.
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The incidence of PPF is growing due to the increasing proportion of older people in the population,
falls, and THAs performed every year. Thus, a demand exists to have a better understanding of all
aspects of surgical- and patient-relevant outcomes of PPF among older adults. In particular, there
has not been a report of PPF after THA evaluating both functional and psychological outcomes
among a Canadian sample of adults. Additionally, a comprehensive evaluation of falls risk, fear
of falling and the functional and psychological impacts of PPF on a person’s life will help healthcare providers implement strategies to optimize the well-being and prevent future falls in this
patient population.
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Chapter 2
Evaluating the functional and psychological outcomes following periprosthetic
femoral fracture after total hip arthroplasty.
2.1 INTRODUCTION
A fracture around the implant of a total hip arthroplasty (THA) after surgery, known as a
periprosthetic femoral fracture (PPF), is a rare and serious complication in older adults. 17,18 The
majority of PPFs after THA in older adults (70% - 81%) occur as a result of falls. 119,120 The
consequences of a PPF can be dire, with most people reporting ongoing pain and difficulty in
regaining pre-PPF functional status despite achieving fracture union after appropriate surgical
treatment for this fracture.17,19,20 Although the incidence of older adults that have a PPF after THA
ranges widely from 0.07% to 18%,116,120,125,126 it is predicted there will be a 4.6% rise in the number
of PPF cases every 10 years over the next 30 years.127 The combination of an aging population and
the higher occurrence of falls among older adults is seen as the driving force behind the expected
increase in PPF.125,127 Therefore, a better understanding of the outcomes of older adults with PPF
is warranted to help guide clinical care.
Previous research on the outcomes of PPF after THA has only evaluated post-surgical
complications, functional outcomes and the mortality rate. Postoperative complications after PPF
surgery are common and include wound infection, re-fracture, dislocation, and aseptic femoral
loosening.19,134–138 Importantly, the mortality rate during the first postoperative year following the
PPF surgery is high at 11% to 17%.18,20,21,138,139,142 Very few studies report functional17,19,20,137,143
and psychological137,143 outcomes following the surgical treatment for this fracture. Only one study
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by Young et al.21 assessed the short-term (e.g., at 6 months) functional outcomes and five other
studies17,19,20,137,143 have reported the long-term functional outcomes with a range of mean
postoperative follow-up periods from 33.6 to 64.9 months. Young et al. 21 found poorer short-term
functional outcomes at 6 months after surgery when compared with a control group of people with
a revision THA for aseptic loosening. Zheng et al. 17 reported worse ambulatory status and poor
hip function at a mean postoperative follow-up period of 38.2 months in patients with PPF after
THA when compared with their preoperative functional status. Although the postoperative followup period in this study ranged from 24 to 60 months, the functional outcome scores were averaged
and the study did not evaluate the pattern of the functional outcomes over the five year period. 17
In addition, only two studies have evaluated both functional and psychological outcomes in the
same cohort of patients and the findings are variable.137,143 In a study by Märdian et al.137 patients
with PPF after THA demonstrated significant long-term functional and psychological deficits at a
mean follow-up of 45 months after undergoing surgery for a PPF. On the other hand, Kinov et
al.143 found 78.6% of the patients with PPF after THA had satisfactory functional and
psychological outcomes at a mean follow-up of 5 years after the PPF surgery.
Several studies identified a number of patient- and surgery-related risk factors that are associated
with an increased risk of sustaining a PPF after THA, such as advanced age, female gender,
inflammatory arthritis, revision THA and cementless stem. 13,15,128,129,144,145 However, literature
identifying factors predictive of functional20,137 and psychological outcomes137 post- PPF surgery
is limited. Only the study by Märdian et al.137 evaluated factors that are associated with the
functional and psychological outcomes. This study reported comorbidities, measured using the
American Society of Anesthesiologists (ASA) score, as a negative predictor. However, they did
not mention the specific ASA score that is associated with worse functional outcomes and what

20

other patient or surgical factors were assessed. It is critical for health-care professionals to identify
specific patient- and surgery-related factors that are associated with reduced outcomes after the
PPF surgery in order to initiate pre- and postoperative interventions, including rehabilitation, to
optimize the recovery after this surgery among older adults.
The current study aimed to reduce the knowledge gap regarding the functional and psychological
outcomes associated with PPF surgery after THA. The objectives of this study were: 1) to define
the clinical and surgical characteristics of people who underwent revision total hip arthroplasty
(rTHA) after PPF, 2) to determine the mortality rate after rTHA due to PPF, 3) to evaluate the
physical and psychological changes over two-years after surgery, and 4) to evaluate the factors
associated with functional and psychological outcomes at one-year after the rTHA for PPF.

2.2 MATERIALS AND METHODS
2.2.1

Study design and participants

This was a retrospective study using an electronic clinical database at London Health Sciences
Centre-University Hospital (LHSC-UH), London, Ontario, Canada. This study was approved by
the Health Sciences Research Ethics Board at the University of Western Ontario and the Clinical
Resources Impact Committee of Lawson Health Research Institute.
Using the electronic clinical database, we identified all patients who had a rTHA with or without
open reduction and internal fixation (ORIF) due to a PPF between 2005 - 2019 in London, Ontario,
Canada. To be fully comprehensive in patient identification billing codes were searched through
for three surgeons who performed the majority of these surgeries at our institution. At our
institution, multiple follow-up appointments are routine between surgery and one-year after
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surgery, and then every 1 - 2 years afterwards. Patients’ baseline demographics and surgical
characteristics were collected from the surgical admission note and then people were followed
forward in time to collect data from subsequent post-surgical follow-up clinic visits, from oneyear to five-years post-surgery, in the outpatient orthopaedic clinics. Charts reviews were
completed between April 29, 2019 and February 29, 2020.
Inclusion criteria were aged 60 years or older and had rTHA with or without ORIF for PPF after
THA or hemiarthroplasty (HA) regardless of the mechanism of the PPF and the surgery was
performed between 2005 - 2019. Patients were excluded if they sustained a PPF during THA
(intraoperative PPF), the fracture was managed conservatively, had a periprosthetic acetabular
fracture after THA, PPF occurred after a Birmingham hip resurfacing or a total knee arthroplasty,
PPF occurred around antibiotic spacer or pathologic lesion, or if the PPF after HA was revised to
HA or Girdlestone resection arthroplasty. Additionally, we excluded patients who underwent
ORIF without revision THA for PPF.
Baseline demographic information extracted from the clinical charts was age, sex, the mechanism
of injury, any previous lower extremity surgeries performed at our institution either on the same
side or opposite side of the PPF surgery, and the index surgical procedure of the hip. The
Vancouver Classification System (Figure 2.1) was used to classify the fractures. This classification
system, developed by Duncan and Masri in 1995, is based on the anatomic location and pattern of
the fracture, the amount of bone loss and prosthesis stability.24,121 Surgical information extracted
was operative diagnosis, surgical approach, type of the fracture fixation (e.g., cable, wire, plate),
and bone grafting (e.g., femoral or acetabular). Additionally, we included any special surgical
techniques (e.g., extended trochanteric osteotomy) and intraoperative events (e.g., trochanteric
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fracture) that occurred during the surgery for the fixation of the PPF. If the fracture type was not
mentioned in the clinical charts, author B.L reviewed the radiographs or computed tomography
(CT) scans to identify and classify the fractures. Usual clinical practice at our facility included the
administration of outcome measures at postoperative follow-up visits. The Harris Hip Score (HHS)
and The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) evaluated
hip joint and physical function, while the Short Form-12 Survey (SF-12) assessed psychological
well-being.
Figure 2.1: The Vancouver classification of periprosthetic femoral fracture.

Note: Vancouver A, Fracture around the trochanteric region (AG= Greater Trochanter, AL= Lesser
Trochanter); Vancouver B, Fracture around the femoral stem (B1= well fixed stem, B2= loose
stem, B3= loose stem with inadequate bone stock); Vancouver C, Fracture distal to the tip of
femoral stem. (Adapted from Francony F, Pailhé R, Gaillot J, Saragaglia D, scidoc.org.
Periprosthetic femoral fracture).
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2.2.2

Outcome measures

2.2.2.1 The Harris Hip Score (HHS)
The HHS is an outcome measure that is collected by the clinician and covers four domains of pain,
function, range of motion, and absence of deformity of the hip joint. 146 The pain domain measures
the severity of pain and the requirement of pain medication while performing daily life activities.
The function domain is subdivided into gait (e.g., walking distance without using assistive devices,
limping examination, mobility aid use) and functional activities (e.g., climbing stairs, tying shoes,
public transport, and sitting). The range of motion domain measures the movement in flexion,
abduction and adduction, and both internal and external rotation of the hip joint. The deformity
domain involves the examination of flexion, abduction, and internal rotation of the hip, and limb
length discrepancy. Every question in each domain is rated on a two to six-point Likert scale. The
overall score has a maximum of 100 points, a higher score represents better hip function. The
minimal clinically important difference, which is the minimal change in scores that are perceived
as beneficial to health, for the HHS ranges from 15.9 to 18 points. 147 In THA patients, the HHS
has demonstrated excellent reliability.148
2.2.2.2 The Western Ontario and McMaster Osteoarthritic Index (WOMAC)
The WOMAC questionnaire assesses pain and physical disability in patients suffering from a
variety of orthopaedic conditions. The WOMAC is comprised of 24 questions divided into three
domains: pain, stiffness, and physical function. 149 Every question in each domain is rated on an
ordinal scale of 0 - 4. The total maximum WOMAC score is 96, where a lower score indicates a
better health outcome. A weighted and inverted conversion of scores was used such that the score
of each domain is out of 100 and higher scores are indicative of better overall health status. The
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minimal clinically important difference for the original version of WOMAC ranges from 9.4 to
25 points.150–152 In patients with THA, the instrument has demonstrated good to excellent testretest reliability across the different subdomains.149
2.2.2.3 The Short Form-12 Survey (SF-12)
The SF-12 is a self-report questionnaire evaluating a person’s overall health-related QoL. 153,154
The instrument is divided into two components: the mental component summary (MCS) and the
physical component summary (PCS) scores. The MCS evaluates mental health, social functioning,
vitality, and role limitations due to emotional problems. The PCS assesses general health, physical
functioning, role limitations due to physical disability, and perceived bodily pain. Both
components are scored on a population-normalized scale, with higher scores indicating better
health outcomes. The reported minimal clinically important difference is 5 points for both
components.155 The SF-12 has shown to be reliable and valid in older adults. 156
2.2.3

Data analysis

Objective #1: Descriptive statistics using means and standard deviations, or frequencies and
percentages were used, as appropriate, to summarize the baseline demographics, clinical, and
surgical characteristics.
Objective #2: A Kaplan Meier curve of cumulative survival for time to death after the PPF surgery
over a period of 12 years was plotted for the whole sample and then the sample stratified by gender.
The cumulative survival time was reported using median and 95% confidence interval. A log rank
test evaluated differences in the survival distributions between males and females. The death was
confirmed by reviewing the clinical charts and searching through online obituary records in the
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public domain. If the death was not confirmed, cases were considered censored based on their last
recorded activity in the electronic database for any inpatient admission or outpatient visit at LHSCUH from the time of the PPF surgery to the end date of the data collection for this study, which
was February 29, 2020.
Objective #3: The scores on WOMAC, HHS, and SF-12 PCS and MCS from the one-year to fiveyears follow-up period were summarized as means and standard deviations. The scores on the
HHS were graded as poor (< 70), fair (70 - 79), good (80 - 89) or excellent (90 - 100). 146 For the
WOMAC and SF- 12 PCS and MCS, scores were compared with the normative data (WOMAC: 157
2.4 (0 - 100 scale, 0 being best outcome and 100 being the worst outcome), and PCS: 158 42.0 and
MCS:158 54.5). Change in WOMAC, HHS, and SF-12 PCS and MCS scores was evaluated using
paired t-tests for people with both one-year and two-years follow-up. The statistical significance
for paired t-tests was corrected for multiple comparisons using the Holm-Bonferroni method, p <
0.013.
People with one-year follow-up data were stratified into fallers and non-fallers based on the
mechanism of the PFF as recorded in the clinical charts and outcome measure scores were
summarized with median and interquartile range (IQR). Mann-Whitney U tests were performed to
compare the outcome scores at one-year post-PPF surgery between fallers and non-fallers.
In addition, comparison of the baseline demographics and surgical information was done between
the patients that had at least one outcome measure score over the five-years follow-up period and
the patients with no available outcome measures data during the period. Another comparison of
the baseline demographics and surgical characteristics was made between the patients that died
within the first postoperative period and those who were alive and had one-year outcome measures
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data. Independent t-tests were used for the comparison between continuous data. Chi-square tests
of homogeneity and Fisher’s Exact test were used for comparison between nominal variables as
appropriate. The normality of continuous data was determined by Shapiro-Wilk tests and the visual
inspection of the normal Q-Q plots. Statistical significance corrected for multiple comparisons was
set at p < 0.008 for the first comparison and p < 0.01 for the second comparison using the HolmBonferroni method.
Objective #4: The association between baseline demographic, clinical, and surgical factors on each
of the one-year post-PPF surgery outcome measures of SF-12 MCS and PCS, HHS and WOMAC
was modelled using linear regression. Initial analysis involved separate univariate linear regression
models for each independent variable. If statistically significant in the univariate analysis,
variables were included in a multivariable linear regression model. Statistical significance
corrected for multiple comparisons was set at p < 0.01 using the Holm-Bonferroni method.
Independent variables of interest were selected based on previous literature and clinical
significance. The following independent variables were assessed for inclusion in the regression
models: age (continuous), sex (male/female), previous lower extremity surgeries performed at our
institution (yes/no), femoral bone grafting (yes/no), and the Vancouver classification. For the
Vancouver classification variable, the fracture types were categorized into two groups based on
the presence of inadequate bone stock surrounding the implant. The four fracture types (AG, AL,
B1, and B2) were combined to form one category and fracture type B3 as another category.
SPSS version 26 (IBM Corporation, Armonk, NY) was used to analyze the data.

2.3 RESULTS
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2.3.1

Baseline demographics & clinical characteristics

An initial 290 rTHAs performed due to a hip fracture were identified between 2005 - 2019 in the
electronic clinical database and 509 hip procedures performed between 2016 - 2019 were extracted
from the billing codes. Cases were then screened to identify the patients that had undergone a
rTHA with or without ORIF due to a PPF (Appendix 2.1). A total of 130 patients were included
in the analysis. At baseline, the average age was 80.6 ± 9.0 years, 55.4% (n= 72) female, and 24.6%
(n= 32) had a history of previous lower extremity surgeries performed at our institution either on
the same side of the PPF surgery or the opposite side. In 66.2% (n= 86) of patients the PPF occurred
after a primary THA, 15.4% (n= 20) patients had the fracture after a HA, 9.2% (n= 12) after a
rTHA, and for 9.2% (n= 12) patients the primary procedures were unknown. The majority of the
patients sustained PPF due to a fall (77.7%, n= 101) and 57.7% (n= 75) had a type B2 Vancouver
classification fracture (Table 2.1).
2.3.2

Surgical characteristics

One hundred and twenty-eight (98.5%) patients had a rTHA and ORIF to fix the fracture, cables
were used to fix 40.0% (n= 52) of PPFs, and 26.2% (n= 34) of patients had both cables and wires
(Table 2.2). A trochanteric fracture occurred during the rTHA for the PPF in 1.5% (n= 2) patients
and wires were used to fix this intraoperative fracture. The acetabular liner was exchanged during
the rTHA for 51.5% (n= 86) of patients, and 14.6% (n= 19) had revision of both the acetabular
liner and cup. In total 26.9% (n= 35) of patients had femoral bone grafting, 3.8% (n= 5) had
acetabular bone grafting, and 3.1% (n= 4) had both femoral and acetabular bone grafting.
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Table 2.1: Demographic and clinical characteristics of the patients who had revision total hip
arthroplasty with or without open reduction and internal fixation for a periprosthetic femoral
fracture. (n= 130)
Variable

Mean ± SD, [Range] or n (%)

Demographic Characteristics
Age (years)

80.6 ± 9.0, [60.3 – 99.7]

Sex, Female

72 (55.4)

Clinical Characteristics
Mechanism of the Periprosthetic Femoral Fracture
Fall

101 (77.7)

Non-traumatic

10 (7.7)

Missing information

19 (14.6)

Vancouver classification of Periprosthetic Femoral Fracture
AG

2 (1.5)

AG and AL

1 (0.8)

B1

5 (3.8)

B2

75 (57.7)

B3

47 (36.2)

Index Surgical Procedure of Hip
Primary Total Hip Arthroplasty

86 (66.2)

Revision Total Hip Arthroplasty

12 (9.2)

Hemiarthroplasty

20 (15.4)

Missing information

12 (9.2)

Previous Lower Extremity Surgeries, Yes*

32 (24.6)

Note: “*” lower extremity surgeries performed at our institution either on the same side of the PPF
surgery or the opposite side.
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Table 2.2: Surgical characteristics of the patients who had revision total hip arthroplasty with or
without open reduction and internal fixation for a periprosthetic femoral fracture. (n= 130)
Variable

Mean ± SD, [Range] or n (%)

Surgical Characteristics
Surgical Approach
Direct Lateral
Posterior

119 (91.5)
11 (8.5)

Main Surgical Procedure for Periprosthetic Femoral Fracture
Revision Total Hip Arthroplasty and ORIF
Revision Total Hip Arthroplasty

128 (98.5)
2 (1.5)

Periprosthetic Femoral Fracture Fixation
Cable

52 (40.0)

Wire

33 (25.4)

Cable and Wire

34 (26.2)

Accord Cable Plate

6 (4.6)

Plate-Screw and Cable

3 (2.3)

No fixation

2 (1.5)

Types of the Special Surgical Techniques
None

109 (83.8)

Extended Trochanteric Osteotomy

15 (11.5)

Extended Trochanteric Osteotomy and Hardware removal

1 (0.8)

Femoral Osteotomy

4 (3.1)

Hardware removal

1 (0.8)

Note: ORIF, Open Reduction and Internal Fixation.

2.3.3

Survival distribution of the study sample
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For the complete sample (n= 130) over a 12-year span, a total of 40% (n= 52) patients died and
60% (n= 78, male= 30 and female= 48) were censored (Figure 2.2). The median survival time from
the time of PPF surgery to death was 5.2 years (95% CI: 4.3, 6.2). The mortality rate for our study
sample was 3.8% (n= 5) at 30 days, 15.4% (n= 20) at one-year, and 38.5% (n= 50) at ten-years
from their surgery for the PPF.
Figure 2.2: Kaplan-Meier curve of the time from the surgery for periprosthetic femoral fracture
surgery to death in years. (n= 130)

When the sample was stratified by sex, 48.3% (28 of 58) of males and 33.3% (24 of 72) of females
died over the 12-years after the PPF surgery (Figure 2.3). The median survival time was 3.8 years
(95% CI: 3.4, 4.2) for males and 7.2 years (95% CI: 4.8, 9.5) for females. There was no statistically
significant difference (p= 0.08) between the groups in survival. The comparison between the
patients that died within the first-year postoperative period and the patients who were alive and
had one-year outcome measures data showed a significant difference for baseline age (p < 0.001)
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and no significant difference (p > 0.01) for sex, mechanism of PPF, Vancouver classification of
PPF, index surgical procedure of hip, and previous history of the lower extremity surgery.
Figure 2.3: Kaplan-Meier curve comparing the difference in the survival time between male and
female groups from the surgery for periprosthetic femoral fracture to death in years; 52 patients
died after PPF surgery within 12 years. (n= 130)

2.3.4

Functional and psychological outcomes after surgery for PPF

Only 54.6% (n= 71) of patients returned to the outpatient clinic one-year after their PPF surgery.
Of these patients, 36.9% (n= 48) had data for at least one of the outcome measures of interest
(Figure 2.4). At year five, only 6 (4.6%) patients returned to clinic and had at least one outcome
measure score. Comparison between the patients with available follow-up outcome measures data
and those with no available values for the outcome measures demonstrated no significant
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differences (p > 0.008) on baseline age, gender, mechanism of PPF, Vancouver classification of
PPF, index surgical procedure of hip, and previous history of the lower extremity surgery.
Figure 2.4: The number of patients that visited orthopaedic outpatient clinic and completed at least
one outcome measure from one-year to five-years after their revision total hip arthroplasty due to
periprosthetic femoral fracture. (n= 130)
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2.3.4.1 Functional and psychological outcomes
The mean total score of the WOMAC was 67.9 ± 20.3 (n= 37) at one-year follow-up after a PPF
surgery (detailed subdomains scores are presented in Table 2.3). Average HHS scores were 78.3
± 15.0 at one-year post-PPF surgery, representing a fair hip joint function (detailed subdomains
scores are summarized in Table 2.3). For SF-12 PCS and MCS, the mean scores at one-year after
a PPF surgery were 34.6 ± 10.8 and 52.7 ± 9.1, respectively. Values for the WOMAC, HHS, and
SF-12 PCS and MCS from the two-years to five-years follow-up visits were present for 2.3% to
20% of patients who were assessed during this time points and had outcome measure values (Table
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2.3). Therefore, change in scores was only determined from one-year to two-years. Change in
scores were non-significant for the WOMAC (n= 17) (Year-1: 70.7 ± 19.7, Year-2: 78.6 ± 15.2;
p= 0.07), and HHS (n= 15) (Year-1: 77.4 ± 17.0, Year-2: 78.6 ± 20.0; p= 0.84) total scores.
Additionally, there was no significant difference in scores for the SF-12 (n= 20) PCS (Year-1: 35.5
± 11.6, Year-2: 35.2 ± 10.2; p= 0.88), and MCS (Year-1: 52.1 ± 10.4, Year-2: 51.2 ± 9.2; p= 0.80).
No statistically significant differences were found between fallers and non-fallers for the WOMAC
total scores at one-year post-PPF surgery [faller (n= 25): median= 69.0 & IQR= 48.2 - 82.6, nonfaller (n= 6): median= 70.0 & IQR= 63.0 - 77.0, p= 0.29], and HHS [faller (n= 24): median= 79.0
& IQR= 73.8 - 87.8, non-faller (n= 5): median= 66.0 & IQR= 66.0 - 79.0, p= 0.18]. Similarly,
there was no statistically significant difference between fallers and non-fallers for the SF-12 PCS
[faller (n= 32): median= 32.2, IQR= 26.2 - 43.5; non-faller (n= 7): median= 28.1 & IQR= 26.2 37.6, p= 0.40], and MCS [faller (n= 32): median= 52.0, IQR= 44.3 - 58.5; non-faller (n= 7):
median= 55.0, IQR= 53.6 - 59.9, p= 0.29].
2.3.5

Factors associated with functional and psychological outcomes at one-year after the
PPF surgery

In total, 24.6% to 35.4 % of patients with baseline data had one-year data available for linear
regression modeling. In the univariate regression analyses, no significant association was found
between age, gender, previous history of lower extremity surgery, the Vancouver classification,
and femoral bone grafting and the outcomes of the WOMAC (Table 2.4), HHS (Table 2.5), SF-12
PCS (Table 2.6) and MCS (Table 2.7) total scores. The multivariable linear regression analyses
were not performed for any of the independent variables as a priori univariate criteria were not
met.
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Table 2.3: Patient’s average scores on the functional and psychological outcome measures from
one-year to five-years after the revision total hip arthroplasty for a periprosthetic femoral fracture.
Domain

Mean ± SD
Year One

Year Two

Year Three

Year Four

Year Five

76.0 ± 22.0
n= 39

87.3 ± 17.9
n= 26

72.9 ± 23.1
n= 14

80.5 ± 24.3
n= 10

82.5 ± 21.8
n= 4

Stiffness

62.5 ± 24.7
n= 39

75.0 ± 22.1
n= 26

65.2 ± 19.7
n= 14

75.0 ± 27.0
n= 10

60.0 ± 28.5
n= 5

Function

62.4 ± 24.0
n= 37

73.7 ± 18.4
n= 26

74.0 ± 18.5
n= 14

76.8 ± 22.2
n= 9

58.7 ± 27.8
n= 5

67.9 ± 20.3
n= 37

79.7 ± 15.3
n= 26

71.7 ± 18.4
n= 14

81.3 ± 18.2
n= 9

73.8 ± 22.7
n= 4

39.0 ± 8.2
n= 37

39.0 ± 9.5
n= 23

38.7 ± 8.8
n= 14

38.9 ± 6.3
n= 7

38.5 ± 6.0
n= 4

30.6 ± 10.4
n= 34

31.1 ± 11.6
n= 22

34.8 ± 11.1
n= 12

33.7 ± 9.9
n= 7

27.7 ± 11.2
n= 3

78.3 ± 15.0
n= 32

78.9 ± 18.7
n= 22

84.8 ± 16.7
n= 11

83.2 ± 15.2
n= 6

74.0 ± 17.4
n= 3

WOMAC scores
Pain

Total score

Harris Hip Scores
Pain

Function
Total score

Short Form-12 Scores
PCS

34.6 ± 10.8
n= 46

34.0 ± 9.9
n= 25

37.1 ± 11.1
n= 15

40.0 ± 11.3
n= 10

37.7 ± 9.7
n= 6

MCS

52.7 ± 9.1
n= 46

51.0 ± 9.2
n= 25

48.3 ± 9.5
n= 15

48.0 ± 11.9
n= 10

52.2 ± 9.8
n= 6

Note: MCS, Mental Component Summary Scale; PCS, Physical Component Summary Scale;
WOMAC, Western Ontario and McMaster Universities Arthritis Index.
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Table 2.4: Linear regression model examining the association between baseline patient’s demographic, clinical, and surgical
characteristics to the WOMAC total score at one-year after the surgery for periprosthetic femoral fracture. (n= 37)
Unadjusted Model
r2

Unstandardized β (95% CI)

p-value

Age (Years)

0

0.02 (- 0.90, 0.94)

0.97

Sex, Male

0

- 2.66 (- 16.80, 11.47)

0.70

0.01

- 3.51 (- 18.48, 11.47)

0.64

0.04

- 9.11 (- 23.81, 5.59)

0.22

0

1.20 (- 13.82, 16.22)

0.87

WOMAC total score at one-year

Previous History of Lower Extremity Surgery,* Yes
Vancouver Classification (AG/AL/B1/B2 or B3)
B3
Femoral Bone Graft, Yes

Notes: WOMAC, Western Ontario and McMaster Universities Arthritis Index. “*” lower extremity surgeries performed at our institution
either on the same side of the PPF surgery or the opposite side. Statistical significance corrected for multiple comparisons using the
Holm- Bonferroni method, p < 0.01.
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Table 2.5: Linear regression model examining the association between patient’s demographic, clinical, and surgical characteristics to
the Harris Hip Score total score at one-year after the surgery for periprosthetic femoral fracture. (n= 32)
Unadjusted Model
r2

Unstandardized β (95% CI)

p-value

Age (Years)

0.16

- 0.76 (- 1.41, - 0.11)

0.02

Sex, Male

0.02

- 3.80 (- 14.95, 7.34)

0.49

Previous History of Lower Extremity Surgery,* Yes

0.07

8.88 (- 2.93, 20.702)

0.14

0.02

4.42 (- 7.08, 15.92)

0.44

0.09

10.98 (- 1.73, 23.68)

0.09

Harris Hip Score total score at one-year

Vancouver Classification (AG/AL/B1/B2 or B3)
B3
Femoral Bone Graft, Yes

Note: “*” lower extremity surgeries performed at our institution either on the same side of the PPF surgery or the opposite side.
Statistical significance corrected for multiple comparisons using the Holm- Bonferroni method, p < 0.01.
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Table 2.6: Linear regression model examining the association between patient’s demographic, clinical, and surgical characteristics to
the Short Form-12 PCS score at one-year after the surgery for periprosthetic femoral fracture. (n= 46)
Unadjusted Model
r2

Unstandardized β (95% CI)

p-value

Short Form-12 Physical Component Summary Score at one-year
Age (Years)

0.06

- 0.35 (- 0.76, 0.06)

0.09

Sex, Male

0.08

- 6.24 (- 12.54,0.07)

0.05

0

- 0.49 (- 7.86, 6.89)

0.90

0.01

1.03 (- 3.32, 5.37)

0.64

0.03

3.72 (- 2.98, 10.43)

0.27

Previous History of Lower Extremity Surgery,* Yes
Vancouver Classification (AG/AL/B1/B2 or B3)
B3
Femoral Bone Graft, Yes

Note: PCS, Physical Component Summary Score. “*” lower extremity surgeries performed at our institution either on the same side of
the PPF surgery or the opposite side. Statistical significance corrected for multiple comparisons using the Holm- Bonferroni method, p
< 0.01.
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Table 2.7: Linear regression model examining the association between patient’s demographic, clinical, and surgical characteristics to
the Short Form-12 MCS score at one-year after the surgery for periprosthetic femoral fracture. (n= 46)

Unadjusted Model
r2

Unstandardized β (95% CI)

p-value

0

- 0.07 (- 0.42, 0.29)

0.70

0.05

- 3.95 (- 9.38, 1.478)

0.15

0

0.37 (- 5.86, 6.60)

0.91

0.04

- 2.39 (- 6.00, 1.22)

0.19

0

- 0.09 (- 5.84, 5.66)

0.98

Short Form-12 Mental Component Summary Score at one-year
Age (Years)
Sex, Male
Previous History of Lower Extremity Surgery,* Yes
Vancouver Classification (AG/AL/B1/B2 or B3)
B3
Femoral Bone Graft, Yes

Notes: MCS, Mental Component Summary Score. “*” lower extremity surgeries performed at our institution either on the same side
of the PPF surgery or the opposite side. Statistical significance corrected for multiple comparisons using the Holm- Bonferroni
method, p < 0.01.
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2.4

DISCUSSION

Patients with a rTHA due to a PPF had fair hip joint function, and poor overall physical function
and psychological well-being. The one-year postoperative mortality rate for our sample was 15.4%
and the study population showed a decline in survival probability over 12-years following the PPF
surgery. The mechanism of the PPF (fall or non-trauma) was not associated with the functional
and psychological outcomes at one-year post-PPF surgery. Despite the complexity of the surgery
and recovery inherent in PPF surgery, we found no further recovery in hip joint function, physical
function, or psychological well-being from one-year to two-years post-PPF surgery. Additionally,
no baseline clinical or surgical characteristic were associated with any of the outcomes of interest
at one-year following the PPF surgery. Our findings in this study are novel and expand the current
knowledge of the long-term adverse effects of PPF surgery on the functional and psychological
well-being in older adults. In addition, this is the first study to have evaluated the impact of the
mechanism of the PPF (falls or non-trauma) on the functional and psychological outcomes at oneyear following a rTHA due to PPF.
Previous research that measured functional outcomes17,19–21,137 with the WOMAC, HHS or Oxford
hip score and psychological outcomes137 using the Short Form-36 MCS for PPF after THA
demonstrated reduced ability in both domains following the surgery, which is comparable with our
results. The study by Kinov et al.143 reported better functional outcomes scores after PPF surgery
compared to the other published studies. The difference between our findings and Kinov et al. 143
is likely related to age difference in the studies, our cohort was 13.7 years older and 30.9% of our
patients with one-year functional data had a history of previous lower extremity surgery compared
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to a relatively younger and healthier cohort. Our population demonstrated better psychological
outcome scores than the Kinov et al.143 cohort, yet these scores are lower than normative data for
age and sex-matched Canadian general population.158 Factors such as comorbidities and
preoperative poor psychological status and disability are known to affect the psychological wellbeing in patients following THA and may be relevant for people after PPF surgery as well. 159 Thus,
future research should evaluate these factors in the evaluation of well-being after the PPF surgery.
The mean follow-up period in existing research varied between 33.6 to 64.9 months 17,19,20,137,143
and provided a summary on outcomes rather than a detailed evaluation over discrete time frames,
for example yearly, which our study was able to evaluate. In our study, patients alive at one-year
post-PPF surgery with outcome measures data and those who died within a year of surgery
significantly differed on the baseline age. Although these groups did not differ on any other
baseline characteristics that we evaluated, it should be considered that we were constrained by the
variables that were collected as part of the routine clinical practice. Therefore, we were unable to
evaluate other relevant factors such as comorbidities, pre-PPF ambulatory status, and preoperative
psychological outcomes scores that could confirm if the patients that were alive and had outcome
measures data were healthier. Thus, there is still a potential that we might have seen a healthy
survivor effect in our study. Additionally, the change in WOMAC, HHS, and SF-12 PCS and MCS
was not statistically significant and did not meet a clinically relevant difference. Therefore, a
dedicated prospective study that is adequately powered should be conducted to evaluate the pattern
of the long-term functional outcomes following the PPF surgery.
The one-year postoperative mortality rate for our study at 15.4% was comparable with the oneyear mortality rate of 17% reported by Moreta et al.20 The study by Moreta et al.20 had a similar
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distribution of sex, mechanism of fracture and used the Vancouver classification of the fractures
as well. In a retrospective study of 291 people with PPFs after THA or total knee arthroplasty,
Drew et al.138 determined advanced age at the time of the surgery as a risk factor for increased
mortality at one-year after the PPF surgery. Consistent with the findings of the Drew et al. 138 study,
the highest number of patients died within the first year after surgery and they were older at the
time of surgery than those who survived.
In this present study, we found no significant association between age, gender, previous lower
extremity surgery, the Vancouver classification, and femoral bone grafting on the functional and
psychological outcomes at one-year following the surgery. Märdian et al. 137 and Moreta et al.20
also reported no significant association between the Vancouver classification on the post-PPF
surgery functional outcome in patients with PPF after THA. In contrast to our study, the Moreta et
al.20 study reported functional outcome in terms of the recovery of the pre-PPF ambulatory status
and they did not evaluate the association between the Vancouver classification on the
psychological outcomes of the surgery. Similar to the two mentioned studies, we had a relatively
small sample size and incomplete one-year outcome measures data following the PPF surgery
resulting in power issues to find a statistically significant association. Therefore, prospective
cohort studies with larger sample sizes and procedures in place to limit losses to follow-up within
the cohort would be beneficial.
There are limitations in the study which need to be acknowledged. In this study, follow-up data
was incomplete after baseline which impacts the power of the study to detect statistically
significant differences. Another potential limitation was a high percentage of censored data for the
survival analysis, which might have led to a conservative estimate of the overall mortality rate for
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our study population. We did not evaluate people who had PPFs that were managed conservatively
or by ORIF without a rTHA at our institution, thus our results are not generalizable to all the
patients who sustain a PPF. Additionally, due to the unavailability of adequate preoperative values
on the patient-reported outcome measures scores, the comparison between pre- and postoperative
functional and psychological outcomes was not possible. In the current study, patients that died
within the first postoperative year were significantly different in baseline age than the cohort of
patients with one-year data that were analyzed. Therefore, our results may not be generalizable for
all the patients who had PPF surgery in our study and may over-estimate functional and
psychological outcomes of the population. Importantly, there are several strengths to the present
study. We included all the patients that had undergone a PPF surgery at our institution within the
last 14 years. Thus, providing a representation of the patient profiles that had undergone PPF
surgery at our institution performed by experienced arthroplasty surgeons.

2.5 CONCLUSION
Our study found that patients with a PPF have fair hip joint function, and poor physical function
and psychological wellbeing at one-year after a rTHA with or without ORIF. This study also
demonstrated a high one-year mortality rate that is comparable to previous research. We found no
significant changes in the functional and psychological recovery between the one and two-years
following the PPF surgery. Future research should focus on assessing the functional and
psychological outcomes at multiple time points and comparing against the preoperative values to
have a clearer understanding of the long-term recovery trajectories of the PPF surgery among older
adults.
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Appendix 2.1: Flow chart for the identification of patients with a revision total hip arthroplasty
after periprosthetic femoral fracture.

Note: ORIF, Open Reduction and Internal Fixation; PPF, Periprosthetic Femoral Fracture; THA,
Total Hip Arthroplasty.
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Chapter 3
Assessing the outcomes and risk of falling after periprosthetic femoral fracture
in older adults.
3.1 INTRODUCTION
Total hip arthroplasty (THA) is a gold standard procedure used to minimize pain and improve
physical function and health-related quality of life in people with advanced hip osteoarthritis; 6,86
however, gait impairments and hip muscle weakness are common after this surgery 9,87,88. These
functional deficits after THA contribute to a higher falls risk in this population 8,106 with
approximately 25% to 36% of people reporting a fall within the first postoperative year 12,106,110.
Sustaining a fall after a THA has serious consequences, one in particular being a fracture around
the implant known as a periprosthetic femoral fracture (PPF).12 The current incidence of PPF
ranges from 0.07% to 11% for primary THA and 1.19% to 18% for revision THA (rTHA), 116,120,125–
127

and it is predicted there will be a 4.6% rise in the number of PPF cases every 10 years over the

next 30 years.127 The combination of an aging population and the higher occurrence of falls among
older adults is seen as the driving force behind the expected increase in PPF. 125,127 Therefore, a
better understanding of the outcomes of older adults with PPF is warranted to help guide clinical
care.
Previous research on the outcomes of the PPF surgery has mainly focused on post-surgical
complications19,134–138 and mortality rate18,20,21,138,139142. Very limited research has evaluated
functional outcomes,17,19–21 specifically only two studies137,143 have assessed both the functional
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and psychological well-being after this surgery in the same cohort of older adults. The functional
status following the PPF surgery in prior studies has mainly used patient-reported questionnaires
with an emphasis on the recovery of pre-PPF ambulatory status. In a retrospective study, Moreta
et al.20 found that 52% of the patients were unable to return to their pre-PPF ambulatory status
even after 2.8 years following the PPF surgery. Zheng et al. 17 demonstrated worsened hip function
and walking ability at a mean postoperative follow-up period of 3.2 years after the PPF surgery
when compared to the preoperative status. Despite the evidence of functional deficits after the PPF
surgery in older adults,17,19–21 no study has used objective physical performance tests to assess gait,
lower extremity strength, and balance after the PPF surgery. It is well established that slower gait
speed,115,160–162 decreased lower extremity strength,161 and balance deficits161 are associated with
the increased risk of falls among older adults. Therefore, a comprehensive physical function
assessment using both subjective patient-reported and objective physical performance tests is
clinically relevant as the results can be utilized for developing fall prevention interventions in this
population.
A previous history of preoperative falls is associated with increased falls risk during the
postoperative period after THA.114 Considering that 70% to 81% of PPFs occur as a result of falls
after THA,119,120 older adults may remain vulnerable to future falls risk following the PPF surgery.
Yet, no literature has examined the falls occurrence, future falls risk, fear of falling, and falls
prevention among older adults with PPF after THA. In general, community-dwelling older adults
have a low perception of personal risk of falls and limited knowledge regarding falls risk factors
and falls prevention strategies.163 Currently, it remains unknown if there is a lack of falls risk
awareness among older adults after the PPF surgery. In order to tailor falls prevention education
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during the postoperative rehabilitation phase in this population, it is critical to evaluate falls-related
risk factor knowledge and falls prevention strategies. Moreover, being aware and knowledgeable
about personal falls risk and falls prevention strategies may promote the development of selfefficacy for initiating active participation in the appropriate strategies to reduce future falls risk.
The limited information regarding the functional and psychological outcomes of PPF surgery in
older adults reinforces the need for a comprehensive evaluation of falls risk and the functional and
psychological impact of PPF surgery on a person’s life. Bridging this gap would help health-care
providers implement strategies to optimize the well-being of this patient population. The present
study was a pilot study performed among people who sustained a PPF as a result of a fall after
THA. The aims of our study were, 1) to determine the occurrence of falls, and to assess fear of
falling, future falls risk, and general knowledge regarding falls and falls prevention strategies
following a PPF surgery due to a fall, 2) to evaluate the functional outcomes of gait, balance, lower
extremity strength, function and disability after a PPF surgery, and 3) to assess the psychological
outcomes of depression symptomatology, social participation and overall quality of life (QoL)
after a PPF surgery in older adults.

3.2 MATERIALS AND METHODS
3.2.1

Study design and participants

This was a cross-sectional study of patients who sustained a PPF after a THA due to a fall and had
the following surgeries to repair the fracture: 1) a rTHA (with or without ORIF) or 2) only ORIF
at the London Health Sciences Centre, University Hospital (LHSC-UH), London, Ontario, Canada.
This study was approved by the University of Western Ontario Health Sciences Research Ethics
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Board and the Clinical Resources Impact Committee of Lawson Health Research Institute. The
study took place between April 29, 2019 to February 29, 2020.
We recruited community-dwelling adults who were 60 years of age or older, had sustained a PPF
due to a fall, and undergone a rTHA or ORIF due to a PPF after either THA, bipolar hip
hemiarthroplasty, or Birmingham hip resurfacing at LHSC-UH, and were between 6-months to 4years after their PPF surgery. Additionally, participants needed to be able to communicate and
follow instructions in English, and be able to ambulate a minimum of 10 meters with or without
the use of a mobility aid. Individuals were excluded if they had sustained a PPF after THA due to
non-traumatic reasons, or had a current clinical diagnosis of dementia or cognitive impairment.
Potential participants were identified from the LHSC-UH electronic database and billing codes
related to the work of three orthopaedic surgeons at our institution. A total of 51 eligible
participants were contacted through letters (Appendix 3.1). Individuals who were interested and
met eligibility criteria as per a phone interview were scheduled to attend the orthopaedic outpatient
clinic for a routine follow-up with their surgeon and the study assessment. The study assessment
took approximately 60 - 120 minutes to complete and participants were allowed to take breaks
during the testing protocol as needed.
The following demographic and medical information were obtained from the participants: age,
sex, height, weight, number and type of prescription medications, self-reported typical physical
activity levels (very active = participating in a structured exercise program 3 times per week;
moderately active = physical activity less than twice per week; inactive = leading a sedentary
lifestyle), weight bearing status, mobility aid use and type, date of PPF, and time between the PPF
and the fixation for PPF. Additionally, patient clinical charts were reviewed and the following
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information was extracted: date and type of primary hip replacement surgery (THA/bipolar hip
hemiarthroplasty/Birmingham hip resurfacing), date of PPF surgery, surgical approach of PPF
surgery, type of fixation for the PPF, implant loosening present or not at the time of the PPF
surgery, and radiographic evidence of healing of the PPF during the most recent follow-up visit
with the surgeon. The Vancouver Classification System (Figure 3.1) was used to classify the type
of fracture. This classification system, developed by Duncan and Masri in 1995, is based on the
anatomic location and pattern of the fracture, the amount of bone loss and prosthesis stability.24,121
Figure 3.1: The Vancouver classification of periprosthetic femoral fracture.

Note: Vancouver A, Fracture around the trochanteric region (AG = Greater Trochanter, AL=
Lesser Trochanter); Vancouver B, Fracture around the femoral stem (B1 = well fixed stem, B2=
loose stem, B3 = loose stem with inadequate bone stock); Vancouver C, Fracture distal to the tip
of femoral stem. (Adapted from Francony F, Pailhé R, Gaillot J, Saragaglia D, scidoc.org.
Periprosthetic femoral fracture).
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3.2.2

Outcome measures

Participants completed one cognitive test, seven self-report questionnaires and four physical
performance tests during the study assessment. A specific order of assessment was maintained for
all participants. Participants performed the physical performance tests in the following order: 6meter Walk Test, Timed-Up-and-Go Test, Step Test, and lastly 30-Second Chair Stand Test.
3.2.2.1 The Montreal Cognitive Assessment (MoCA)
Global cognition was measured using the Montreal Cognitive Assessment (MoCA). The MoCA is
a reliable and valid tool to evaluate global cognitive status in older adults. 164 It assesses seven
cognitive domains including, short-term memory recall, visuospatial skills/executive functions,
attention, concentration, working memory, language, and orientation to time and place. An
additional point is given to participants with less than 12 years of education. The score ranges from
0 - 30 and a score of 25 or less indicates a mild cognitive impairment. 164
3.2.2.2 Self-report measures
3.2.2.2.1 The Modified Cumulative Illness Rating Scale (m-CIRS)
Comorbidities were reported using the Modified Cumulative Illness Rating Scale (m-CIRS). 165
The m-CIRS covers 14 independent organ systems which are graded on severity of impairment
from a 0 (no impairment) to 4 (extremely severe impairment) for each organ system. The total
score is the sum of the individual scores and ranges from 0 - 56. A high score represents severe
multi-organ failure. In older adults, a total score of 21 or more is associated with a high in-hospital
mortality rate and requiring additional services after discharge. 166 The m-CIRS is a reliable
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instrument in older adults.167
3.2.2.2.2 Falls questionnaire
A self-report questionnaire was administered that included 38 questions regarding falls (see
Appendix 3.2 for the full questionnaire) divided into three sub-sections: 1) falls after PPF surgery
(14 questions), 2) the knowledge of falls risk factors (14 questions), 3) falls prevention strategies
(10 questions). In addition, five questions about the perceived functional changes and three
questions about the perceived psychological changes post-PPF surgery were administered.
To quantify any fall occurrences after the PPF, a fall was defined as “an unexpected event in which
the participants come to rest on the ground, floor, or lower level”. 100 Participants were asked about
the number of falls since the PPF surgery, time after surgery in which the falls took place, number
of falls within the last 6 months from the current follow-up clinic appointment, site of injuries as
a result of the falls and whether or not medical attention was sought. Injuries were classified as
major or minor. Major injury was defined as any event such as fracture, dislocation, head trauma
(e.g., concussion) which required medical attention, whereas minor injury denoted soft tissue
injuries (e.g., bruises, lacerations) in which medical attention may or may not be required.
Participants who experienced falls were asked to describe the types of activities they were involved
in when falls occurred and whether or not the experience of falls affected their confidence level in
performing daily life activities. Participants were also asked whether they now use a mobility aid
for activities which they were able to perform without the mobility aid before PPF surgery.
The questions regarding falls risk factors were modified from the falls risk factors questionnaire
developed by Braun et al.163, which inquires on four knowledge facets: 1) physical factors , 2)
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psychological factors, and 3) interior environmental factors and 4) exterior environmental factors.
The wording on the questions was modified for people with a PPF surgery. Participants rated their
responses on how likely each of 13 specific risk factors would make a person fall regardless of a
history of PPF surgery on a 10-point Likert scale ranging from 0 (not at all likely) to 10 (most
likely). Participants were also asked if they believe falls can be prevented among people who have
had surgery for a PPF.
The 10 questions about falls prevention strategies implemented after PPF surgery were modified
from the falls prevention strategies questions developed by Hunter et al. 168. The wording on the
questions was modified for people with a PPF surgery. Participants were asked to rate on a 10point Likert scale the importance of falling in their life compared to their other health concerns (0
being not at all and 10 being the most important). Participants were asked if they feel unsteady
when walking after PPF surgery. They were also asked if they were taught by health-care
professionals about falls prevention strategies to reduce falls after PPF surgery. Participants were
also asked if they believed they would fall at some point within the next 12 months. Additionally,
they were asked to rate using a 5-Likert scale (strongly agree, agree, undecided, disagree, strongly
disagree) if they believed they would be able to return to their current living situation if they fell
and injured themselves due to the fall.
Participants were also asked three open-ended questions about any falls prevention strategies they
had implemented since their PPF surgery, and strategies still to be put into place and their
confidence in their ability to implement these strategies. The responses on the open-ended question
were classified based on the work of Hill et al.169 into the following five categories: 1) behavioural
strategies (e.g., “pay more attention”, “do not go outside for shopping”), 2) support while
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mobilizing strategies (e.g., “use handrails”, “wear well-fitted and better shoes”), 3) movementrelated modifications (e.g., “moved into an apartment”, “reduced walking”), 4) physical
environment modifications (e.g., “use hospital bed”, “no carpet in house”), and 5) activity and
exercise engagement.
3.2.2.2.3 Perceived functional changes post-PPF surgery
Participants were asked if they had modified any daily activities after the PPF surgery. If a person
responded with “yes”, they were further asked to provide the list of activities they have modified
since the PPF surgery. Participants were also asked about the potential reasons (e.g., pain, reduced
balance, mental fatigue, physical fatigue, lack of endurance, lack of support) for which they have
modified their daily life activities after the PPF surgery.
3.2.2.2.4 Perceived psychological changes post-PPF surgery
Information was also solicited with yes/no questions for whether participants felt socially isolated
and frustrated with their current situation of life since their PPF surgery. An open-ended question
about the psychological impact of the surgery in their life was also asked.
3.2.2.2.5 The Activities-specific Balance Confidence (ABC) Scale
The ABC scale is a 16 item self-report measure of a person’s level of confidence in performing
various functional activities without falling or experiencing a sense of unsteadiness. 170 Each item
is rated on a scale ranging from 0% (no confidence) to 100% (completely confident). The total
score is calculated by adding the responses of each item and dividing it by the total number of
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items. The ABC scale has high retest reliability and internal consistency in community-dwelling
older adults.170
3.2.2.2.6 The Falls Risk for Older People-Community setting (FROP-Com)
The FROP-Com is a questionnaire that assesses 25 risk factors that are associated with increased
fall risk in older adults. There are 28 self-report questions ranked on either a dichotomous scale
(yes or no) or an ordinal scale of 0 to 3 (0 being better outcome and 3 being worst outcome). The
question “does the home appear safe” on the FROP-Com was excluded from the calculation of
total score as the study assessment was completed outside the home, and no home assessment was
performed. The overall score is the sum of each question for a maximum score of 60. Participants
with scores of 0 - 11 are considered to have mild falls risk, 12 - 18 are considered of moderate falls
risk and 19 - 60 scores are indicative of high falls risk. The FROP-Com has excellent intra-rater
reliability and good inter-rater reliability in older adults. 171
3.2.2.2.7 The Late Life Functional and Disability Instrument (LLFDI)
The LLFDI is a self-report measure of functional and disability outcomes in older adults. LLFDI
has two components, the functional component (FC) 172 and the disability component (DC)173.
LLFDI-FC assesses the degree of difficulty in performing 32 socially defined life tasks. The FC is
comprised of an overall function domain and three subdomains: 1) upper extremity (7 items), 2)
basic lower extremity (14 items), and 3) advanced lower extremity functions (11 items). There are
eight additional items for assistive device users. The score for each question ranges from 1 to 5,
with higher scores representing less difficulty in performing that activity. The raw score of the
overall function domain (sum of the 32 items and 40 items for assistive device users) and each
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subdomain’s score are transformed into a scaled score (0 - 100). Participants with high scores have
a high level of functional ability in performing socially defined life tasks.
LLFDI-DC has 16 questions that assess the degree to which a person can perform (disability)
socially defined life tasks. Each question has two disability dimensions, frequency and limitation.
The frequency dimension focuses on how often personal (7 items) and social (9 items) role
activities are performed, whereas the limitation dimension focuses on the limitation in performing
instrumental (11 items) and management (4 items) role activities. Each question is rated on a 5point Likert scale ranging from 1 to 5 (1 being never and 5 being very often) in the performance
frequency dimension and 1 to 5 (1 being not at all and 5 being completely) for the limitation
dimension. To calculate the raw score, items from each dimension or their role domains are
summed. The raw scores are transformed into a 0 - 100 scale. Participants with high scores are
considered to have less disability and those with low scores indicate more disability in performing
socially defined life tasks.
For each item in LLFDI-FC and LLFDI-DC, a question was added to the questionnaires to ask
participants if performance on that activity was the same, better or worse than how it was before
the PPF surgery. LLFDI has shown to be reliable and valid instrument in community dwelling
older adults.172–174
3.2.2.2.8 The Geriatric Depression Scale-Short Form (GDS-SF)
The GDS-SF is comprised of 15 questions to measure depressive symptomatology in geriatric
patients.175 The total score of five or more indicates depressive symptomatology and poorly
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perceived health-related QoL in older adults.175,176 The GDS-SF scale has a high retest reliability
in older adults.175
3.2.2.2.9 The World Health Organization Quality of Life (WHOQOL-BREF)
The WHOQOL-BREF is a self report questionnaire to assess a person’s overall QoL. 177
WHOQOL-BREF is comprised of 26 questions, 24 questions are divided into four domains
(physical, psychological, social, and environmental) and two questions assess a person’s overall
perception of their QoL and health status. Each question is rated on a 5-point Likert scale (1= poor
QoL and 5= good QoL). The mean score of the items within each domain is summed to get a raw
score for that domain. The raw score of each domain is transformed into a 0 - 100 scale. Higher
scores in a domain indicate better QoL in that aspect of life. In older adults, a domain score of less
than 60 indicates a poorly perceived QoL in the represented domain. 178,179 The instrument items
have demonstrated high test-retest reliability in general population. 180
3.2.2.3 Physical function measures
3.2.2.3.1 6-Meter Walk Test
Spatiotemporal gait parameters were collected using wireless accelerometers (LEGSys™,
Biosensics LLC, Watertown, MA) during the performance of the 6-Meter Walk Test. The main
parameter of interest was gait speed since a velocity of less than 1.0 m/s is associated with
increased falls risk.160,181 Five sensors were placed on each participant with Velcro straps, with
one sensor around the back of the waist, two sensors at the midpoint of both thighs anteriorly, and
two sensors at the mid-calf of each leg anteriorly. Participants were instructed to walk a 6-meters
distance at their usual comfortable walking speed using their preferred mobility aid as needed.
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3.2.2.3.2 Timed-Up-and-Go Test (TUG)
The TUG measures a person’s functional mobility (i.e., gait and balance involved in normal daily
life activities).182 Participants began the test by sitting in a standard height chair with armrests (seat
height 46 cm and arm height 65 cm). When asked, participants stand and walk 3 meters at their
usual comfortable pace, turn around, walk back to the chair and return to the initial seated position.
Time to complete the TUG is recorded to the nearest hundredths of a second using a stopwatch.
The participants were allowed to use their assistive device while performing the test if required.
The participants with the highest scores (i.e., longer time to complete) were considered to have
poorer functional mobility. The TUG shows a moderate predictive validity for the occurrence of
the falls in community dwelling older adults. 183
3.2.2.3.3 Step Test
The Step Test measures dynamic balance during an activity that requires weight-shifting and
movement while in single-leg stance.184 Participants were provided a step measuring 15 cm in
height, placed 5 cm in front of their foot. Participants began the test by placing both feet parallel
and 15 cm apart on the floor. On the instruction of the examiner, participants placed one foot on
the step and back down to the floor. Participants were required to repeat the process as many times
as possible within the 15 seconds. Each leg was examined separately. The score was the number
of steps completed within the 15 seconds for each leg. The Step Test has good test re-test and interrater reliability for measuring balance of lower extremity in older adults with hip OA with interrater reliability.185
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3.2.2.3.4 30-Second Chair Stand Test (30sec CST)
The 30sec CST is a performance test for measuring the lower extremity strength in older adults. 186
The participants were instructed to begin the test from sitting in a chair (seat height of 45 cm from
the floor) with a straight back and arms folded across their chest. At the examiner’s signal “Go”,
participants stood up from the chair and returned to the initial position immediately; repeating the
task as many times as possible in 30 seconds. During this test participants were not permitted to
use a gait aid. The number of repetitions was recorded. The 30sec CST is a reliable and valid
indicator of lower extremity strength in older adults with good test-retest reliability. 186
3.2.3

Data analysis

Participant demographics, clinical, and surgical characteristics, and the data from the outcome
measures (MoCA, m-CIRS, falls questionnaire, ABC, FROP-Com, LLFDI, GDS-SF, WHOQOLBREF, 6-Meter Walk Test, TUG, Step Test, and 30sec CST) were summarized using median and
inter-quartile range (IQR) or frequencies and percentages, as appropriate. Reponses on the openended questions in the falls questionnaire were categorized into five themes by two authors (R.I,
S.W.H). Frequency and percentages were used to summarize the responses in each category for
the open-ended questions. The scores on the physical performance tests were compared with the
normative data (TUG:187 ≤ 12 seconds, Step Test:188 15.6 steps, 30sec CST:189 male= 14.2
repetitions, female= 12.7 repetitions) for age and sex-matched community-dwelling adults, and
the proportion of the sample that scored below the established normative data was calculated. SPSS
version 26 (IBM Corporation, Armonk, NY) was used to analyze the data.
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3.3 RESULTS
3.3.1

Demographic, clinical, and surgical characteristics

In total, ten people participated in the study. The median age was 75.5 years (IQR: 70.0 to 81.3
years), six (60.0%) were male, and the median time from the PPF surgery was 2.8 years (IQR: 2.2
- 3.1 years) (Table 3.1). The median m-CIRS total score was 6.5 (IQR: 5.8 - 12.0), indicating all
the study participants exhibited some degree of impairment in the 14 major organ systems. The
majority of the participants (70.0%) reported current use of a mobility aid since the PPF surgery
(cane: 40.0% and walker: 30.0%), and five (50.0%) reported using the mobility aid for all daily
life activities. Seven (70.0%) participants had hip implant loosening at the time of the PPF surgery
and nine (90.0%) had a rTHA to fix the fracture (Table 3.2).
Table 3.1: Demographic and clinical characteristics of older adults with periprosthetic femoral
fracture surgery. (n= 10)
Variable
Age (Years)
Sex, Male
Body Mass Index (kg/m2)

Median, [IQR] or n (%)
75.5 [70.0 – 81.3]
6 (60.0)
26.2 [23.8 – 33.6]

Physical Activity Level
Seldom Active

2 (20.0)

Moderately Active

5 (50.0)

Very Active

3 (30.0)

Full Weight Bearing Status

10 (100.0)

Number of Prescription Medications

7.0 [2.8– 10.8]

Modified Cumulative Illness Rating Scale, Total Score

6.5 [5.8 – 12.0]

Montreal Cognitive Assessment Score

26 [23.8 – 27.3]
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Table 3.2: Surgical characteristics of older adults with periprosthetic femoral fracture surgery. (n=
10)
Variable

Median, [IQR] or n (%)

Index Hip Procedure
Total Hip Arthroplasty

9 (90.0)

Birmingham Hip Resurfacing

1 (10.0)

Vancouver Classification
B1

3 (30.0)

B2

4 (40.0)

B3

3 (30.0)

Implant Loosening at the time of the surgery, Present

7 (70.0)

Evidence of Radiographic Healing during study assessment,* Present

10 (100.0)

Time (days) between the PPF and the surgical fixation for the fracture

5 [2 – 10]

Surgical Procedure for fixation of PPF
Revision Total Hip arthroplasty

3 (30.0)

Revision Total Hip arthroplasty & ORIF

6 (60.0)

ORIF

1 (10.0)

Surgical Side, Right
Surgical Approach, Direct Lateral

6 (60.0)
10 (100.0)

Note: ORIF, Open Reduction and Internal Fixation; PPF, Periprosthetic Femoral Fracture. ‘*’
indicates radiographic evidence of healing of the periprosthetic femoral fracture during the most
recent follow-up visit with the surgeon.
3.3.2

Falls occurrence of the study sample

Five (50.0%) participants had experienced at least one fall since the PPF surgery, one of them
(10.0%) sustained two falls after the PPF surgery and one (10%) reported sustaining a shoulder
fracture due to falling which required medical treatment to fix the fracture. The majority of the
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falls (40.0%) occurred more than one-year after their PPF surgery and only one (10.0%)
experienced a fall within 6 weeks to 3 months post-PPF surgery. Additionally, three (30.0%)
participants reported the fall affected their confidence level, six (60%) participants stated they are
afraid of falling and had stopped performing activities that they were physically capable of doing,
and four (40.0%) reported using a mobility aid to do activities that had required no mobility aid
before their surgery.
3.3.3

Fear of falling

The median ABC score was 73.5% (IQR: 41.9% - 90.9%). The lowest balance confidence was
reported for the following three activities: ‘walking outside on icy sidewalks (Median: 10.0%,
IQR: 0% - 50.0%)’, ‘standing on a chair and reaching for something (Median: 50.0%, IQR: 0% 62.5%)’, and ‘bumping into by people when walking through mall (Median: 50.0%, IQR: 20.0%
- 90.0%)’. The confidence was highest for ‘reaching for a small can off a shelf at eye level (Median:
100.0%, IQR: 80.0% - 100.0%)’, ‘walking across a parking lot to the mall (Median: 100.0%, IQR:
77.5% - 100.0%)’, and ‘walking outside the house to a car parked in the driveway (Median:
100.0%, IQR: 70.0% - 100.0%)’.
3.3.4

Future falls risk: Falls Risk for Older People - Community setting Questionnaire
(FROP-Com)

The median FROP-Com score was 9 (IQR: 7 to 13 points), indicating mild falls risk after their
PPF surgery. A total of 18 risk factors associated with future falls were identified with median
number of risk factors of 6.5 (IQR: 4.8 - 9.5). The most identified risk factors were ‘number of
medical conditions affecting balance (100%)’, and ‘number of prescription medication (90%)’ and
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the least identified risk factors were ‘observed behaviours during activities of daily living and
mobility (10.0%)’, and ‘prior to fall, how much assistance required in activities of daily living
(10.0%)’.
3.3.5

Falls risk factors knowledge

The majority (60.0%) of the participants believed falls among people who have had a PPF surgery
could be prevented. Risk factors for falls given the highest scoring were: ‘walking on icy sidewalks
(Median: 10.0, IQR: 9.8 - 10.0)’, ‘doing unsafe or risky activities (Median: 10.0, IQR: 7.3 - 10.0)’,
‘balance/coordination problem (Median: 9.5, IQR: 6.5 - 10.0)’ and ‘not paying attention to
surroundings (Median: 9.0, IQR: 7.3 - 10.0)’. Participants rated ‘being forgetful (Median: 5.0,
IQR: 3.5 - 8.5)’, ‘taking many medications (Median: 6.0, IQR: 4.3 - 9.3)’, and ‘rugs and furniture
(Median: 6.5, IQR: 5.0 - 10.0)’ as the lowest factors leading to an increased risk of falls in older
adults.
3.3.6

Falls prevention measures

The median rating on the importance of falling compared to their other health concerns was 8
(IQR: 5 - 10) out of 10. Four (40.0%) rated falling the most important compared to their other
health concerns. The majority of the participants (70.0%, n= 7) reported being taught by healthcare professionals about prevention of falls after the PPF surgery and only three (30.0%)
participants reported that they expect to fall sometime within the next 12 months period. When
asked if they believe they can return to their current living condition if they sustained a falls-related
injury, eight (80.0%) participants agreed and two (20.0%) participants were undecided.
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A total of 11 modifications for in-home/daily life activities were made by six (60.0%) participants
to reduce the falls risk after PPF surgery. The median number of modifications was one (IQR: 0 3.3). The majority of the modifications were made in their physical environment (40.0%), such as
installing grab bars in the bathroom (20.0%), using a commode chair for toilet seat (10.0%),
modifications in the height of table (20.0%) and chair (20.0%), using a hospital bed (10.0%),
keeping a light on at night time and for dark places at home (10.0%), removing tripping hazards
(10.0%), keeping a spare mobility aid in different locations (20.0%), and installing a chairlift on
the stairs (10.0%). The behavioural modifications included being attentive to the surroundings
(10.0%). The modifications adopted to provide support while walking were wearing well-fitted
shoes (10.0%) and using the handrails to climb stairs (20.0%). Only two (20.0%) participants had
plans to make modifications in their daily life activities in near future. In total, seven (70.0%)
participants expressed an interest in learning about the falls prevention measures.
3.3.7

Functional outcomes after PPF surgery

3.3.7.1 Perceived functional changes post-PPF surgery
Six participants (60%) reported that they had to modify their daily life activities as a result of their
PPF surgery (Figure 3.2). The most reported reasons for modifying their daily life activities after
PPF were physical pain (50.0%) and reduced balance (50.0%). Other listed reasons for the
modifications in daily life activities were mental fatigue, physical fatigue, lack of endurance, lack
of support, due to other health conditions, fear of being alone or in a compromised situation, and
fear of falling.
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Figure 3.2: Distribution of modifications made to daily life by participants as a result of
periprosthetic femoral fracture surgery. (n= 10)

3.3.7.2 Spatiotemporal gait parameters
The 6-Meter Walk Test was completed by eight (80.0%) participants, with four (40%) participants
using their mobility aid during the test. The median gait velocity for our study sample was 0.8 m/s
(IQR: 0.6 - 0.8 m/s), and the majority of the participants (7, 87.5%) walked at speeds slower than
1.0 m/s.
3.3.7.3 Functional mobility, lower extremity balance and strength
The median time to complete the TUG test (n= 10) was 12.0 seconds (IQR: 9.7 - 18.6). In total,
five (50.0%) participants had slower TUG times by 0.5 - 19.3 seconds when compared to age and
sex-matched normative values. In total, seven (70%) and eight (80%) participants participated in
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the Step Test and 30sec CST, respectively. Three (30%) participants were excluded from the Step
Test and two (20%) from 30sec CST due to a reported lack of confidence to perform the test
without their mobility aid. The median scores on the Step Test for the affected side and nonaffected side for our study sample were 10 (IQR: 9 - 14) and 12 (IQR: 10 - 12), respectively. Seven
(100.0%) participants had lower scores in both the affected and non-affected sides for the Step
Test compared to the age and sex-matched normative values. The median number of stands in
30sec CST test was 11.5 (IQR: 10.0 - 15.8). In total, five (62.5%) participants had scores below
age and sex-matched normative values.
3.3.7.4 The Late Life Functional and Disability Instrument (LLFDI)
The median score for the functional component of the LLFDI was 49.6 (IQR: 37.2 - 59.3). Median
scores for the basic and advanced lower extremity subdomains were 57.0 (IQR: 42.8 - 64.6) and
29.4 (IQR: 14.7 - 48.2), respectively. The median number of activities considered as worse
performance compared to the patient’s status before PPF surgery was 11.5 (IQR: 4.3 - 18.3) out of
32. Participants scored 46.6 (IQR: 40.7 - 51.2) and 66.9 (IQR: 59.2 - 83.4) in the frequency and
limitation dimensions of the LLFDI-DC component, respectively. Overall, 2.5 (IQR: 0 - 6.5) of
items in DC were rated as worse performance compared to the status before PPF surgery.
3.3.8

Psychological outcomes and overall quality of life after PPF surgery

3.3.8.1 Psychological outcomes after PPF surgery
Half of the study sample (50.0%) felt socially isolated and was frustrated about the current situation
after their PPF surgery. When asked an open-ended question regarding the psychological impact
of PPF surgery, five (50.0%) participants reported frustration over their physical limitations as a
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result of the PPF surgery (Figure 3.3). The median GDS-SF scores was 2.0 (IQR: 0.8 - 3.0),
indicating no depressive symptomatology. The responses on the GDS-SF that represented
depression were notable for six (60.0%) participants who felt a lack of energy in life after the PPF
surgery, five (50%) preferred being at home rather than going out, and three (30%) participants
had dropped many of their activities after their surgery and were feeling bored.
Figure 3.3: Responses in people after periprosthetic femoral fracture surgery on question “How
has the periprosthetic femoral fracture surgery impacted your life psychologically?”. (n= 10)

3.3.8.2 Quality of life: The World Health Organization Quality of Life-BREF (WHOQOLBREF)
There were eight (80.0%) participants who completed all the items within the questionnaire. The
majority of the participants (90%) rated their general QoL good or very good. Participants scored
lower on the physical and psychological domains with a median score of 57.1 (IQR: 46.4 - 62.5)
66

and 58.3 (IQR: 50.0 - 66.7), respectively, indicating a perceived poor QoL in these domains. The
score on the environmental domain was the highest (Median: 78.1, IQR: 71.9 - 84.4), representing
a higher perceived satisfaction with the environmental conditions. The social domain score was
calculated for 8 (80.0%) participants with a score of 62.5 (IQR: 58.3 - 72.9).

3.4 DISCUSSION
Even after years from the PPF surgery, participants reported functional difficulty and reduced
functional ability to perform socially defined daily life activities. Participants also stated that their
performance on the majority of the activities had decreased compared to their pre-PPF surgical
status. In the physical performance tests, the majority of the participants demonstrated slower gait
speed, and deficits in functional mobility, dynamic balance, and leg strength compared with age
and sex-matched healthy older adults. Half the sample reported at least one fall since the PPF
surgery and most falls occurred after the first year. Moreover, participants demonstrated a lack of
awareness of falls risk factors and limited implementation of falls prevention strategies in their
daily life after the PPF surgery. We found no depressive symptomatology; however, social
isolation and frustration over the physical limitations as a result of the PPF surgery were common
in our study sample. Participants also perceived a poor QoL in their physical and psychological
facets of life after the PPF surgery. To the authors' knowledge, the findings of this study are novel
and add valuable information on the understanding of the impact of the PPF surgery on the wellbeing of older adults.
Participants in our study reported difficulty in activities that required greater physical ability and
endurance, walking, standing, and stooping. Participants also reported a reduction in daily life
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activities. Compared to their pre-surgical status participants reported worse performance after their
PPF surgery for most of the activities. Our findings are consistent with existing research that found
functional deterioration17,19,20,137 and poorer walking ability17,20 were common post-surgery for
PPF when compared to preoperative status, even years after the event. In contrast to previous
studies that collected surgeon-reported disease specific outcome measures, our use of a patientreported measure provides a novel and more holistic view of the impact of the PPF surgery on
daily life activities of older adults.
Falls risk in older adults is multifactorial and is dependent upon the interaction between intrinsic
and extrinsic risk factors.101 A recent meta-analysis identified the intrinsic factors of balance
deficits, and fear of falling, and the extrinsic factor of prescription medications as important
determinants for falls risk after THA.111 Specifically, this study reported that the odds of falling
were 4.09 times larger in patients taking medications after THA compared to those not taking any
medications post-THA.111 Consistent with this body of literature, the FROP-Com identified
balance deficits and the higher number of prescription medications as the most common falls risk
factors in our sample. Additionally, the balance confidence measured by the ABC scale was
73.5%, previous research in community-dwelling older adults found a score less than 80% is
indicative of functional decline and increased fall risk requiring an intervention. 190 The use of
objective physical performance tests in our study identified a large proportion of our sample had
deficits in lower extremity strength, balance and functional mobility. However, of the physical
performance tests used in our study only gait speed has robust predictive validity for future falls
risk.160,182 The majority of our study participants walked at a gait speed of < 1.0 m/s which in older
adults is associated with an increased risk of falls. 115,160,162 Although we used portable wireless
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accelerometers to measure the gait speed, it can also be measured using a stopwatch to time
walking a 6-meter distance. Therefore, a quick gait assessment during the postoperative evaluation
may aid health-care professionals in identifying the people that are at high risk of future falls postPPF surgery.
The falls occurrence in our sample was higher (50% versus 36%) compared to the reported falls
occurrence within 2 to 7.8 years after a primary THA reported by Ikutomo et al. 106 This is likely
due to the difference in the time reference, postoperative functional status, and the age group of
the study samples. We captured all the falls that occurred post-PPF surgery in an older sample with
a higher functional impairment, whereas Ikutomo et al. 106 reported falls that occurred within the
past year in a relatively younger and healthier cohort. Considering most of our sample’s falls
occurred after the first year, we suggest that falls risk assessment should be performed beyond the
immediate one-year postoperative period. Despite perceiving the importance of falling as a health
issue, participants had a lack of understanding of the personal risk of falling and underestimated
the negative consequences of the falls. Participants also demonstrated diverse perceptions of
knowledge regarding established falls risk factors, which reflected on their application of falls
prevention strategies. While the highest-rated falls risk factors were behavioural, most
modifications reported were within their physical environment. Structured exercise is the most
effective falls prevention intervention in older adults; 191 however, none of the participants in the
present study adopted such modification to prevent falls post-PPF surgery. Our findings on falls
knowledge indicate that better communication is needed between the health-care professionals and
the participants to help them implement proven falls prevention strategies.
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Participants in our study indicated being dissatisfied with their physical and psychological wellbeing after PPF surgery but adequately satisfied with social and environmental aspects of life. This
might be explained by the fact that the physical and psychological aspects of the WHOQOL cover
the relevant areas (e.g., pain, physical function, acceptance of the bodily appearances) of the
functional and psychological limitations from the PPF surgery. On the other hand, the social and
environmental components mainly focus on satisfaction over personal relationships, home
environment, transportation, and access to health services. Märdian et al. 137 reported a poor QoL
in patients after PPF surgery (mean postoperative follow-up period: 3.8 years), which are
comparable with our results. Conversely, the study by Kinov et al.143 found higher values of healthrelated QoL in patients at a mean follow-up of 5 years after PPF surgery compared to other studies.
The discrepancy between results of our study and Kinov et al. 143 may be related to the difference
in the study designs and the age group of the study samples. Specifically, participants in the
retrospective study by Kinov et al. were relatively younger compared to our older sample. The
contradictory results found between these studies and the present study reinforce the need for more
research to assess the QoL in this population.
There are limitations in this study that need to be acknowledged. In this study, we did not include
people that sustained a PPF due to non-traumatic reasons and the findings are not generalizable to
all the people who sustain a PPF. Another limitation was the retrospective report of falls over a
duration of 4-years. The reporting of falls occurrence based on the recall memory of the study
participants has a potential for under-reporting of falls. 100 Thus, the falls occurrence in this study
may be a conservative estimate. To provide a more accurate occurrence of falls, future research is
recommended to minimize recall bias through the use of a daily falls calendar and follow-up calls
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over a prospective time frame. Additionally, there are no established normative data in the
literature for the LLFDI instrument which prevented us from comparing our data with age and sexmatched normative values. There are several strengths of the study that should be acknowledged.
The main strength of the study is the in-depth evaluation of functional status after the PPF surgery
using both physical performance tests and patient-reported outcome measures. This is the first
study that has evaluated the falls occurrence and falls knowledge among older adults with a PPF
surgery, adding valuable information for clinicians that can be utilized to adjust the falls prevention
education delivered during the rehabilitation phase to minimize the falls occurrence in this
population. In this study, we included the participants whose PPF surgery was performed by three
certified orthopaedic surgeons with a specialization in THA surgery. These surgeons performed
the majority of the PPF surgery within the last four-years, providing a representation of the patient
profile that had undergone PPF surgery at our institution during this period.

3.5 CONCLUSION
The current study found functional impairment in the performance of daily life activities well
beyond the one-year postoperative period among older adults with a PPF due to falls after THA.
Deficits were demonstrated in gait, functional mobility, dynamic balance, and lower extremity
strength compared to age and sex-matched healthy adults. Social isolation and poor perception of
QoL in physical and psychological facets of life were common in this population. Additionally,
falls occurrence in this sample was higher than that reported in primary THA cohorts. Our in-depth
evaluation of falls knowledge indicated a knowledge gap regarding known risk factors and
effective falls prevention strategies exists. More studies should be conducted that evaluate
functional status utilizing both patient-reported outcome measures and physical performance tests
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and also the subjective evaluation of psychological outcomes to improve the quality of life of this
population.
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Appendix 3.1: Flow chart of enrolled participants.
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Appendix 3.2: Falls Questionnaire.
Falls Information
1. Have you had any falls since having your PFF surgery? (This includes from the day of your
surgery to this follow-up clinic appointment today)
 Yes
 No
2. How many falls have you had since your surgery?
 One
 Two
 Three or more
3. At what time after your surgery did you fall? (CHECK ALL THAT APPLY)
 During hospital stay right after the surgery
 Discharge from hospital to 6 weeks after the surgery
 6 weeks to 3 months after the surgery
 3 months to 6 months after the surgery
 6 months to 12 months after the surgery
 More than 12 months after the surgery
4. Did you sustain any other fracture(s) other than the periprosthetic femoral fracture after your
PFF surgery?
 Yes (Go to question # 5)
 No (Go to question # 7)
5. What kind of fracture(s) did you have after your PFF surgery? (Please list the site and side
of the fracture(s))
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
6. Did you seek any medical attention because of the fracture(s) mentioned in question # 5?
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 Yes
 No
7. Have you had any falls within the last 6 months?
 Yes (Go to question # 8)
 No (Go to question # 14)
8. How many falls have you had within the last 6 months?
 One
 Two
 Three or more
9. Did you injure yourself from any of the falls in the last 6 months?
 Yes (Go to question # 10)
 No (Go to question # 11)
10. Where did you injure yourself? (CHECK ALL THAT APPLY)


Head /Neck

Yes No



Trunk

Yes No



Arm

Yes No



Leg

Yes No

11. Did you seek any medical attention because of the fall(s) in the last 6 months?
 Yes
 No
12. Please describe the activity you were doing when you fell. (Refer back to question # 2)
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
13. Did the fall affect your confidence?
 Yes
 No
75

14. Are you afraid of falling, such that you have stopped doing activities you are physically
capable of doing?
 Yes
 No
15. If you answer ‘Yes’ to the question # 14, please describe the activities you have stopped due
to fear of falling since the PFF surgery (e.g., climbing stairs, driving, walking on uneven
surfaces)
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
16. Do you now use a gait aid/accompaniment to do activities you could do before your surgery
without the aid?
 Yes
 No
Functional outcome measures:

17. Did you have to modify any of your daily activities after PFF surgery?
 Yes (Go to question # 18)
 No (Go to question # 22)
18. If you answer ‘Yes’ to the question # 17, please list the activities you have modified (e.g.,
moved to ground floor, stopped driving, stopped climbing stairs, stopped walking on uneven
surfaces) since the surgery?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
19. Have you modified any of your daily activities after the PFF surgery due to the following
reasons?
 Pain

 Reduced balance

 None (Go to question #

20)
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 Physical fatigue

 Lack of endurance

 Mental fatigue

 Lack of support

20. Are there any other reasons that are not included in question #19, for which you had to
modify your daily activities after the PFF surgery?
 Yes (Go to question # 21)
 No (Go to question # 22)
21. If you answer ‘Yes’ to the question # 20, please list the potential reasons for which you had
to modify your daily life activities after the PFF surgery?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Falls Knowledge
22. Do you believe that falls among people who have had a PFF surgery can be prevented?
 Yes
 No
For each of the next 13 questions, please rate how important each of these scenarios are in
making a person more likely to fall, whether they have had a PFF surgery or not.
23. People are likely to fall because things such as rugs and furniture get in the way.
0

1

2

3

4

5

6

7

8

9

Not at all likely

10

Most likely

24. People are likely to fall because grab bars are not present or are not in a helpful position in
their house or apartment.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

25. People are likely to fall because sidewalks and streets are not clear of ice and snow.
0

1

2

3

4

5

6

7

8

9

10
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Not at all likely

Most likely

26. People are likely to fall because sidewalks and streets are poorly maintained (e.g. cracked or
irregular pavement).
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

27. People are likely to fall because handrails are not present or are poorly positioned in public
places.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

28. People are likely to fall because they have a coordination or balance problem.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

29. People are likely to fall because they do not have enough muscle strength or endurance in
their legs.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

30. People are likely to fall because their bones are weakened with age (osteoporosis).
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

31. People are likely to fall because they have poor vision.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

32. People are likely to fall because they do unsafe or risky things.
0

1

2

Not at all likely

3

4

5

6

7

8

9

10

Most likely

33. People are likely to fall because they do not always pay close attention to their surroundings.
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0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

34. People are likely to fall because they are forgetful.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

35. People are likely to fall because they take many medications.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

36. On a scale from 0 to 10, where 0 means “not at all important” and 10 means “most
important”, how important is falling compared with your other health concerns?
0

1

2

3

4

5

6

7

8

Not at all important

9

10

Most important

37. Do you feel unsteady when walking?
 Yes
 No
38. Do you think you will fall at some time in the next 12 months?
 Yes
 No
39. If you fell and seriously injured yourself (defined as injury such as fracture, dislocation, head
trauma that required medical attention), do you think you would be able to return to your
current living situation?
Strongly agree

Agree

Undecided

Disagree

Strongly disagree

40. After your PFF surgery, do you remember being taught by any health care professionals
about strategies to prevent falls after the surgery?
 Yes
 No
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41. Please describe any things you have modified in your daily activities and/or home to reduce
the risk of falling since having your PFF surgery.
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
42. Please list any things that you plan to modify in your daily activities and/or home to reduce
the risk of falling
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
43. Do you feel confident you will be able to make the changes you have listed in question #42?
 Yes
 No
44. Is there something that might make it difficult for you to do the changes you listed in question
#42 are?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
45. I am very keen to lower my risk of falling by using the strategies I listed in question #42.
Strongly agree

Agree

Undecided

Disagree

Strongly disagree

46. I am interested in learning more about how to prevent falls.
Strongly agree

Agree

Undecided

Disagree

Strongly disagree

Psychological Outcome Measures:
47. Do you feel socially isolated after the PFF surgery?
 Yes
 No
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48. Do you feel frustrated with your current situation?
 Yes
 No
49. How has PFF surgery impacted your life psychologically?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
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Chapter 4: GENERAL SUMMARY
The main objective for the present thesis was to have a better understanding of the functional and
psychological outcomes following the PPF surgery in older adults. In study 1, a fair hip joint
function and poor overall physical function and psychological well-being was demonstrated by
patients at one-year following their PPF surgery. The one-year mortality rate was high, though
comparable to previous studies. We found no significant changes in the functional or psychological
outcomes between one and two-years post-surgery. Additionally, we found no significant
association between baseline clinical and surgical characteristics and functional and psychological
outcomes at one-year following the surgery.
To better understand the functional and psychological outcomes and future falls risk post-PPF
surgery, study 2 evaluated both subjective and objective measures of physical function, subjective
psychological status, overall QoL, falls occurrence, and falls knowledge in older adults after the
PPF surgery. Subjectively, participants reported reduced functional ability to perform most of their
daily life activities. Objectively, and in agreement with subjective physical function results,
participants demonstrated deficits in gait, functional mobility, dynamic balance, and lower
extremity strength compared to age and sex-matched normative data. Additionally, social isolation
and a poor satisfaction with the physical and psychological aspects of life were reported.
Approximately half of the sample experienced a fall after the PPF surgery, which is higher than
after primary THA. People also had a low perception of personal falls risk and underestimated the
negative consequences of falls. Participants also demonstrated a lack of knowledge regarding
known falls risk factors and effective falls prevention strategies.
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The findings of these studies are novel and add valuable information to better understand the
impact that PPF surgery has on the well-being of older adults. It is without a doubt, that patients
with PPF experience low physical and psychological well-being after their surgery with no change
being observed over an extended period of recovery for those survive. This suggests that the
evaluation of rehabilitation protocols for functional and psychological recovery is warranted to
achieve better outcomes in this population. Our findings also suggest that falls risk assessment and
fall prevention education should be delivered in more effective ways during the postoperative
rehabilitation process in this population.

Chapter 5: FUTURE DIRECTIONS
Future research should involve using a prospective cohort study design with an adequately
powered sample size to evaluate the primary outcomes from these studies. Additionally, future
studies should also assess recovery beyond two-years after PPF surgery. Although difficult to
collect, assessment of pre-PPF surgical status to compare to postoperative evaluation will provide
fuller understanding of the recovery trajectories. Comorbidities and preoperative poor
psychological status and disability are factors known to affect the psychological well-being in
patients post-THA and may also be relevant for people after PPF surgery. 159 Therefore, future
research should evaluate these factors in the evaluation of psychological well-being in this
population. Utilizing both subjective and objective physical function measures has been found
beneficial in capturing the physical deficits (e.g., balance deficits, muscle weakness) that may
remain unidentified by self-reported questionnaires.87 To provide a more accurate occurrence of
falls, future research is recommended to minimize recall bias through the prospective use of a daily
falls calendar and follow-up calls over the duration of the study. Additionally, it would be relevant
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to assess the differences in the functional and psychological outcomes between the people who
experience a fall and those do not post-PPF surgery as falls can lead to the reduced health-related
QoL in older adults.104,105 Given the knowledge gap regarding effective falls prevention strategies
in this patient population, it should also be a priority to assess if different educational interventions
(e.g., internet-based workshops, brochures delivered during outpatient clinics) help patients to
implement effective strategies.
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Appendix B: Letter of Information and Consent
School of Physical Therapy
Letter of Information
Quantifying the functional and psychological outcomes after Peri-Prosthetic Femoral
Fracture in association with Total Hip Arthroplasty and Total Knee Arthroplasty in older
adults
Study Principal Investigator: Dr. Susan Hunter PT PhD
Co-Investigators: Dr. Brent Lanting, Dr. James L. Howard, Dr. Edward M. Vasarhelyi,
Dr. Lyndsay Somerville
Introduction
You are being invited to participate in a research study because you had a surgery for a fracture
around your hip/knee joint replacement. Fracture around hip/knee joint replacement is known as
a periprosthetic femoral fracture (PFF). This study is for the MSc thesis of Rifat Islam in the
School of Physical Therapy at the University of Western Ontario.
The study will be looking at how a PFF affects a person’s overall quality of life in terms of both
physical and psychological well-being, and future risk of falls after this fracture.
The purpose of this letter is to provide you the details of the study to help you with making a
decision about participation in this study. It is important that you know about the purpose of the
study and what it will involve. Please take your time to make a decision about participation, and
discuss this proposal with your orthopedic surgeon, family members and friends. Participation in
this study is voluntary.
Description of study
After a PFF most people develop limitations in their daily life activities due to problems with
walking, balance, and weakness in the leg muscles. Accidental falls are the most common cause
of PFFs.
Falls in older adults are common and a significant public-health concern as one third of people
over the age of 65 will fall each year. Falls can cause serious injuries such as fractures and
injuries to the head. Problems with walking, balance and leg strength after PFF can result in an
increased risk of future falls. At this moment, we know very little about the falls that occur and
the future falls risk after PFF.
PFF can have physical and psychological effects on a person. There are very few studies that
have looked at future falls risk, and the physical and psychological effects that a PFF has on a
person’s life. It is important for health care providers to understand the impact of this kind of
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injury in a person’s life in order to put in place interventions to improve quality of life and
prevent future fall risk in older adults.
If you agree to participate in this study, information will be collected by interview and review of
your medical charts related to total hip/knee joint replacement surgery and PFF surgery. You will
also be asked information about any falls that have occurred since your PFF surgery. You will be
asked to complete the following questionnaires and physical function tests as part of the study
assessment.
List of questionnaires:
Questionnaire:

Purpose

1

To test your memory

2

To assess your health status

3

To assess your functional status after your PFF surgery

4

To determine future falls risk after your PFF surgery

5

To assess fear of falling after your PFF surgery

6

To evaluate overall quality of life after your PFF surgery

7

To assess psychological impact of PFF surgery

List of physical function tests:
Physical
function
test:

Purpose of the test

Description of the test

1

To test walking

We will ask you to walk a 6-meter distance at your
comfortable walking pace wearing 5 small accelerometers
(size- 4×5 cm), a device that will be attached with Velcro
straps around your arms and legs to record information on
your walking.

2

To test functional
mobility

You will be asked to rise out of a chair and walk 3 meters
before turning around and returning to the chair.

3

To test balance

While in standing, you will be asked to repeatedly place one
foot at a time on a step to test your balance (repeated for left
and right foot).

4

To test leg strength

You will be asked to rise out of a chair as many times as
possible in a 30 second time period to test your leg strength.

You will be able to use your usual mobility aid during the walk and functional mobility tests. If
you are unable to perform the other two physical function tests without the support of your

113

mobility aid, you will not be asked to do these tests for safety purposes. The graduate student,
Rifat Islam will be present at all times to ensure a safe environment and prevent any falls.
Participation in the study requires only one visit that will take place in the orthopedic surgery
outpatient clinic of the London Health Sciences Centre – University Hospital at the same time as
your appointment to see the orthopaedic surgeon. The study assessment will take approximately
45-60 minutes to complete.
Participation
We are looking for 100 volunteers who are 60 years of age or older, who had surgery for a PFF
at London Health Sciences Center - University Hospital due to a fall, and who are between 6
months to 4 years after the PFF surgery. Volunteers must be able to walk independently with or
without a mobility aid (e.g., cane or walker) for 10 meters without assistance and be able to
provide informed consent for themselves. However, there are certain conditions that would
exclude you from participating in this study. These conditions are as follows: unable to provide
informed consent and follow instructions in English, unable to walk 10 meters without the
assistance of another person, and current diagnosis of cognitive impairment. If you are unsure
whether any of these situations applies in your case, please feel free to ask the research staff.
Withdrawal
Participation in this study is voluntary. You may refuse to participate, refuse to answer any of the
questions, or withdraw from the study at any time with no effect on your future care. If you
choose to withdraw from the study, any information that was provided will not be used for any
study purposes.
Risk and Benefits
Risks
The risks associated with taking part in this study are minor. The physical tests involve movements
that are common in daily activities and thus do not pose any extra risk beyond these levels of
activity. There is a risk of falls. All tests will be conducted by the graduate student, Rifat Islam
with experience in the assessment of physical function in older adults. Safety belts will be used,
and Rifat Islam will always remain within arms’ reach to ensure safety should you lose your
balance. You will be able to have rest breaks during the assessment should you get tired. In case
of any study related injury, medical care will be provided at no cost under the supervision of your
orthopaedic surgeon. As with any research there is the risk of breach of patient confidentiality. To
reduce the risk of this breach, all identifiable data will be de-identified and only study team
members will have access to it.
Benefits
You may not benefit directly from your participation in this study.
Reimbursement for Participation in the study
You will not be paid to participate in this research project.
Cost
We anticipate that the study procedure may add up to 45-60 mins to your regular clinic visit. If
your clinic visit is longer than anticipated, additional parking will not be reimbursed.
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Confidentiality
All records and research materials that would identify you will be held confidential and, to the
extent permitted by the applicable laws and regulations, will not be made publicly available. If you
agree to participate in this study, you will be assigned a unique identification number that will be
used on all the documents related to this study. This unique number will be linked to your name
and contact information on another “master list” of participants. This master list will be kept
separately from the other research information in a locked office. All information collected will be
kept for a period of 15 years. If the results of this study were to be published in the medical
literature, your identity will not be revealed. Lawson Health Research Institute and Western Health
Sciences Research Ethics Board (HSREB) will retain the right to access data collected in this study
in accordance with the Quality Assurance Evaluation Program (QAEP).

Version Date: 19th July 2019
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School of Physical Therapy
Consent Form
Study Title: Quantifying the functional and psychological outcomes after Peri-Prosthetic
Femoral Fracture in association with Total Hip Arthroplasty and Total Knee Arthroplasty
in older adults
Principal Investigator: Dr. Susan Hunter PT PhD
I have read the Letter of Information, have had the nature of the study explained to me, and I
agree to participate. All questions have been answered to my satisfaction.
_________________________________
Participant’s Name (Printed)
_________________________________
Participant’s Signature

_______________________
Date (dd/mm/yyyy)

I confirm that I have explained the nature, purpose, and foreseeable effects of the trial to the
participant whose name is printed above. The participant consented to participate by his/her
personally signed signature.

________________________________
Name of Person Obtaining Consent

_______________________
Role in Study

_______________________________
Signature of Person Obtaining Consent

________________________
Date (dd/mm/yyyy)

Version Date: 19th July 2019
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Appendix C: Letter to Recruit

(Date)
Dear _____________________,
Enclosed please find the letter of information for a study being conducted in the
Department of Orthopaedic Surgery at London Health Sciences Centre (LHSC) with patients
who had surgery for a fracture around their hip/knee joint replacement implant, known as a
periprosthetic femoral fracture (PFF). The study is called “Quantifying the functional and
psychological outcomes after Peri-Prosthetic Femoral Fracture in association with Total Hip
Arthroplasty and Total Knee Arthroplasty in older adults”. Our research team for this study is
comprised of Principal Investigator-Dr. Susan Hunter and Co-Investigators- Dr. Brent Lanting,
Dr. James L Howard, Dr. Edward M Vasarhelyi, and Dr. Lyndsay Somerville.
You are being contacted because you have an upcoming visit and I have identified you
as being potentially eligible to participate in this study. This letter of information describes the
research study and your role if you decide to participate. The purpose of the study is to evaluate
how a PFF affects a person’s life both physically and psychologically, and evaluate the risk of
future falls. The graduate student, Rifat Islam, will contact you by phone within a month of you
receiving this letter to see if you would like to participate. We will attempt to contact you on
three occasions within the one-month time period. There is no obligation to speak with Rifat
Islam and all study participation is voluntary. All information used for the research study will be
kept confidential and you will not be identified personally in any publications or
communications resulting from this study. You do not waive any legal rights by agreeing to
participate in this study.
Please do not hesitate to contact us at the numbers listed in the letter of information if you
have any questions or concerns. Thank you for taking the time to consider this study.
Yours truly,
Dr. Lanting, Brent
Orthopaedic Surgeon at LHSC-University Hospital
339 Windermere Rd, London, ON, N6A 5A5
Version Date: 15th April 2019
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(Date)
Dear _____________________,
Enclosed please find the letter of information for a study being conducted in the
Department of Orthopaedic Surgery at London Health Sciences Centre (LHSC) with patients
who had surgery for a fracture around their hip/knee joint replacement implant, known as a
periprosthetic femoral fracture (PFF). The study is called “Quantifying the functional and
psychological outcomes after Peri-Prosthetic Femoral Fracture in association with Total Hip
Arthroplasty and Total Knee Arthroplasty in older adults”. Our research team for this study is
comprised of Principal Investigator-Dr. Susan Hunter and Co-Investigators- Dr. Brent Lanting,
Dr. James L Howard, Dr. Edward M Vasarhelyi, and Dr. Lyndsay Somerville.
You are being contacted because you have an upcoming visit and I have identified you
as being potentially eligible to participate in this study. This letter of information describes the
research study and your role if you decide to participate. The purpose of the study is to evaluate
how a PFF affects a person’s life both physically and psychologically, and evaluate the risk of
future falls. The graduate student, Rifat Islam, will contact you by phone within a month of you
receiving this letter to see if you would like to participate. We will attempt to contact you on
three occasions within the one-month time period. There is no obligation to speak with Rifat
Islam and all study participation is voluntary. All information used for the research study will be
kept confidential and you will not be identified personally in any publications or
communications resulting from this study. You do not waive any legal rights by agreeing to
participate in this study.
Please do not hesitate to contact us at the numbers listed in the letter of information if you
have any questions or concerns. Thank you for taking the time to consider this study.
Yours truly,
Dr. Howard, James L
Orthopaedic Surgeon at LHSC-University Hospital
339 Windermere Rd, London, ON, N6A 5A5
Version Date: 15th April 2019
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(Date)
Dear _____________________,
Enclosed please find the letter of information for a study being conducted in the
Department of Orthopaedic Surgery at London Health Sciences Centre (LHSC) with patients who
had surgery for a fracture around their hip/knee joint replacement implant, known as a
periprosthetic femoral fracture (PFF). The study is called “Quantifying the functional and
psychological outcomes after Peri-Prosthetic Femoral Fracture in association with Total Hip
Arthroplasty and Total Knee Arthroplasty in older adults”. Our research team for this study is
comprised of Principal Investigator-Dr. Susan Hunter and Co-Investigators- Dr. Brent Lanting,
Dr. James L Howard, Dr. Edward M Vasarhelyi, and Dr. Lyndsay Somerville.
You are being contacted because you have an upcoming visit and I have identified you as
being potentially eligible to participate in this study. This letter of information describes the
research study and your role if you decide to participate. The purpose of the study is to evaluate
how a PFF affects a person’s life both physically and psychologically, and evaluate the risk of
future falls. The graduate student, Rifat Islam, will contact you by phone within a month of you
receiving this letter to see if you would like to participate. We will attempt to contact you on three
occasions within the one-month time period. There is no obligation to speak with Rifat Islam and
all study participation is voluntary. All information used for the research study will be kept
confidential and you will not be identified personally in any publications or communications
resulting from this study. You do not waive any legal rights by agreeing to participate in this study.
Please do not hesitate to contact us at the numbers listed in the letter of information if you
have any questions or concerns. Thank you for taking the time to consider this study.
Yours truly,
Dr. Vasarhelyi, Edward M
Orthopaedic Surgeon at LHSC-University Hospital
339 Windermere Rd, London, ON, N6A 5A5
Version Date: 15th April 2019
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Appendix D: Telephone Call Screening Tool
Study: Quantifying the functional and psychological outcomes after Peri-Prosthetic Femoral
Fracture in association with Total Hip Arthroplasty and Total Knee Arthroplasty in older adults

Telephone Call Screening Tool
Date (DD/MM/YYYY): ___________________
Recruitment Identifier:
Screening Questions
Yes

No

1. Are you 60 years of age or older?
2. Are you able to understand English?
3. Do you have any problems following instructions in English?
4. Are you able to provide signed informed consent for
yourself?
5. Are you able to walk for 10 meters with or without a mobility aid and
without the help of another person?
6. Did you have a fracture around your hip/knee replacement implant due
to falls?
7. Did you have your surgery for this fracture at London Health Sciences
Centre, University Hospital?
8. Are you between 6 months to 4 years from this surgery?
9. Do you have a current diagnosis of dementia or any
other conditions that might affect your cognition or how
you think?
(The use of the word “you” refers to the person who had peri-prosthetic femoral fracture
surgery being asked the question directly. Responses in grey boxes indicate an exclusion
criterion has been met)
Signature
Version Date: 19th July 2019

Date
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Date __________________ dd/mm/yyyy

Study ID#_______________

Cumulative Illness Rating Scale (CIRS)
Scale
0.
1.
2.

No problem affecting that system
Current mild problem or past significant problem
Moderate disability or morbidity and/or requires
first-line therapy

3.

Severe problem and/or constant and significant
disability and/or hard-to-control chronic problems
Extremely severe problem and/or immediate
treatment required and/or organ failure and/or
severe functional impairment

4.

Ratings
Rated 0
•
•
•
•
•

Rated 3

No problems or healed minor injuries
Past childhood injuries (eg, chickenpox)
Minor surgery (eg, amygdalectomy)
Uncomplicated healed fractures
Other past problems healed without sequel
(eg, pneumonia)

•

•
•

Rated 4

Rated 1
•

•
•
•

Current medical problem with mild discomfort
or disability, or occasional exacerbations (eg,
occasional heartburn relieved with PRN antiacids)
Minor impact on morbidity
Past significant medical problems not currently an
issue (eg, passage of a kidney stone)
Major surgery (eg, hysterectomy)

•
•

•
•
•

Rated 2
•

•

Chronic conditions that are not controlled
with first-line therapy (eg, asthma needing
continuous corticosteroid therapy)
Constant significant disability
Severe problem

Extremely severe problem
Any acute condition that requires immediate
treatment (eg, severe bronchospasm, unstable
angina)
Organ failure (eg, end-stage renal disease/dialysis,
O2 for COPD)
Severe sensory impairment (eg, almost complete
blindness or deafness, wheelchair-bound)
Quality of life severely affected, severe functional
impairment

Medical condition that requires daily treatment
(first-line therapy; eg, steroids – asthma, H2
blockers – acid reflux)
Moderate disability or morbidity

Rating Malignancies
Rated 1
•

Rated 3

Cancer diagnosed in the remote past without
evidence of recurrence or sequel in the past
10 years or skin cancer operated in the past
without major sequel (other than melanoma)

•

Rated 4
•

Rated 2
•

Required chemotherapy, radiation, or hormonal
therapy in the past 5 years

Recurrent malignancy, metastasis, or palliative
treatment stage

No evidence of recurrence or sequel in the past
5 years
1 of 4
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Study ID: _______________

Date: ________________

The Activities-specific Balance Confidence (ABC) Scale*
Instructions to Participants: For each of the following activities, please indicate your level of
confidence in doing the activity without losing your balance or becoming unsteady from choosing one
of the percentage points on the scale from 0% to 100% If you do not currently do the activity in
question, try and imagine how confident you would be if you had to do the activity. If you normally
use a walking aid to do the activity or hold onto someone, rate your confidence as if you were using
these supports.
0%

10

20

30

40

50

60

70

No Confidence

80

90

100%

Completely Confident

How confident are you that you will not lose your balance or become unsteady when you…
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.

…walk around the house?
%
…walk up or down stairs?
%
…bend over and pick up a slipper from the front of a closet floor?
%
…reach for a small can off a shelf at eye level?
%
…stand on your tip toes and reach for something above your head?
%
…stand on a chair and reach for something?
%
…sweep the floor?
%
…walk outside the house to a car parked in the driveway?
%
…get into or out of a car?
%
…walk across a parking lot to the mall?
%
…walk up or down a ramp?
%
…walk in a crowded mall where people rapidly walk past you?
%
…are bumped into by people as you walk through the mall?
%
…step onto or off of an escalator while you are holding onto a railing?
%
…step onto or off an escalator while holding onto parcels such that you cannot hold onto
the railing? %
16. …walk outside on icy sidewalks?
%

Total ABC Score:
Scoring: Total ABC Score / 16 =_____________% of self confidence

128

129

130

131

132

Late Life FDI: Function Component

133

134

135

Late Life FDI: Disability Component

136

137

Geriatric Depression Scale (Short Form)
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Study Id#________________

Date:_____________dd/mm/yyyy
The following questions ask about how completely you experience or were able to do certain
things in the last four weeks.
Not at all

A little

Moderately

Mostly

Completely

10. Do you have enough energy for
everyday life?

1

2

3

4

5

11. Are you able to accept your
bodily appearance?

1

2

3

4

5

12. Have you enough money to
meet your needs?

1

2

3

4

5

13. How available to you is the
information that you need in
your day-to-day life?

1

2

3

4

5

14. To what extent do you have the
opportunity for leisure
activities?

1

2

3

4

5

Very poor

Poor

Neither poor
nor good

Good

Very good

1

2

3

4

5

Very
dissatisfied

Dissatisfied

Neither
satisfied nor
dissatisfied

Satisfied

Very
satisfied

16. How satisfied are you with your
sleep?

1

2

3

4

5

17. How satisfied are you with
your ability to perform your
daily living activities?

1

2

3

4

5

18. How satisfied are you with
your capacity for work?

1

2

3

4

5

19. How satisfied are you with
yourself?

1

2

3

4

5

15. How well are you able to get
around?
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Study Id#_________________

Date:_____________dd/mm/yyyy

20. How satisfied are you with your
personal relationships?

1

2

3

4

5

21. How satisfied are you with
your sex life?

1

2

3

4

5

22. How satisfied are you with the
support you get from your
friends?

1

2

3

4

5

23. How satisfied are you with the
conditions of your living place?

1

2

3

4

5

24. How satisfied are you with your
access to health services?

1

2

3

4

5

25. How satisfied are you with
your transport?

1

2

3

4

5

The following question refers to how often you have felt or experienced certain things in the
last four weeks.
Never

26. How often do you have
negative feelings such as blue
mood, despair, anxiety,
depression?

5

Seldom

4

Quite often

3

Very often

2

Always

1
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Data Collection Form
Participant Information:
Age:

____________________

Sex:

Male ( )

Female ( )

Height: ____________________ cm / Inches Weight: ___________ kg / Lb.
Types of joint replacement surgery: (CHECK BOTH IF APPLY)
 Hip replacement (Total hip arthroplasty/hip hemiarthroplasty/ Birmingham hip
resurfacing):

____________________________dd/mm/yyyy

Side: L R

____________________________dd/mm/yyyy

Side: L R

Date of PFF:

____________________________ dd/mm/yyyy

Side: L R

Type of PFF:

____________________________

Date of PFF surgery:

____________________________ dd/mm/yyyy

 Total Knee replacement:

Side: L R

Surgical approach of PFF surgery: ____________________________
Type of the fixation for PFF:

____________________________

Time between the PFF and the fixation for PFF: __________________ Days/Weeks/Months
Implant Loosening:

 Present

 Absent

Medical Information:
Comorbidities:
CIRS Score

__________________________ Date Completed: _____/ _____/ ________

Number of prescription medications currently taking? _________
List of medications:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
____________________________________________________________________________
General Activity Level:
Physical activity Level:
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Which of the following best describes your typical activity level?
● Vigorously active for at least 30 minutes, 3 times per week (i.e., exercise program)
● Moderately active at least 3 times per week
● Seldom active, prefer more sedentary activities
Weight bearing status:
Non-Weight Bearing

Toe-Touch Weight Bearing

Weight Bearing as Tolerated

 Full Weight Bearing

Partial Weight Bearing

Mobility Aid Use:
Use a mobility aid for walking? Yes
How often use a mobility aid?

 No

Intermittently

Please explain ________________________

All the time
What type of mobility aid currently used:
 Cane

Clutches

Evidence of Radiographic healing:  Present

Walker (Type ______________________)
 Absent

Cognitive Assessment:
MoCA Score:

__________________________ Date Completed: _____/ _____/ ________

Falls Assessment:
ABC Score:

__________________________ Date Completed: _____/ _____/ ________

FROP-Com Score:

__________________________ Date Completed: _____/ _____/ ________

Functional and Disability Assessment:

LLFDI Score:

__________________________ Date Completed: _____/ _____/ ________

Lower Extremity Strength Assessment:
TUG Score:

__________________________ Date Completed: _____/ _____/ ________
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30Sec CST Score:

__________________________ Date Completed: _____/ _____/ ________

Balance Assessment:
Step Test Score:

__________________________ Date Completed: _____/ _____/ ________

Gait Assessment:
Gait

Completed

Usual Gait
PFF Outcome Measures:
Harris Hip Score:

__________________________ Date Completed: _____/ _____/ ________

SF-12 Score:

__________________________ Date Completed: _____/ _____/ ________

WOMAC Score:

__________________________ Date Completed: _____/ _____/________

Falls Information
1. Have you had any falls since having your PFF surgery? (This includes from the day of
your surgery to this follow-up clinic appointment today)
 Yes
 No
2. How many falls have you had since your surgery?
 One
 Two
 Three or more
3. At what time after your surgery did you fall? (CHECK ALL THAT APPLY)
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 During hospital stay right after the surgery
 Discharge from hospital to 6 weeks after the surgery
 6 weeks to 3 months after the surgery
 3 months to 6 months after the surgery
 6 months to 12 months after the surgery
 More than 12 months after the surgery
4. Did you sustain any other fracture(s) other than the periprosthetic femoral fracture after
your PFF surgery?
 Yes (Go to question # 5)
 No (Go to question # 7)
5. What kind of fracture(s) did you have after your PFF surgery? (Please list the site and
side of the fracture(s))
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
6. Did you seek any medical attention because of the fracture(s) mentioned in question # 5?
 Yes
 No
7. Have you had any falls within the last 6 months?
 Yes (Go to question # 8)
 No (Go to question # 14)
8. How many falls have you had within the last 6 months?
 One
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 Two
 Three or more
9. Did you injure yourself from any of the falls in the last 6 months?
 Yes (Go to question # 10)
 No (Go to question # 11)
10. Where did you injure yourself? (CHECK ALL THAT APPLY)


Head /Neck

Yes No



Trunk

Yes No



Arm

Yes No



Leg

Yes No

11. Did you seek any medical attention because of the fall(s) in the last 6 months?
 Yes
 No
12. Please describe the activity you were doing when you fell. (Refer back to question # 2)
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
13. Did the fall affect your confidence?
 Yes
 No
14. Are you afraid of falling, such that you have stopped doing activities you are physically
capable of doing?
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 Yes
 No
15. If you answer ‘Yes’ to the question # 14, please describe the activities you have stopped
due to fear of falling since the PFF surgery (e.g., climbing stairs, driving, walking on
uneven surfaces)
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
16. Do you now use a gait aid/accompaniment to do activities you could do before your
surgery without the aid?
 Yes
 No
Functional outcome measures:
17. Did you have to modify any of your daily activities after PFF surgery?
 Yes (Go to question # 18)
 No (Go to question # 22)
18. If you answer ‘Yes’ to the question # 17, please list the activities you have modified (e.g.,
moved to ground floor, stopped driving, stopped climbing stairs, stopped walking on
uneven surfaces) since the surgery?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
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19. Have you modified any of your daily activities after the PFF surgery due to the following
reasons?
 Pain

 Reduced balance

 Physical fatigue

 Lack of endurance

 Mental fatigue

 Lack of support

 None (Go to question # 20)

20. Are there any other reasons that are not included in question #19, for which you had to
modify your daily activities after the PFF surgery?
 Yes (Go to question # 21)
 No (Go to question # 22)
21. If you answer ‘Yes’ to the question # 20, please list the potential reasons for which you
had to modify your daily life activities after the PFF surgery?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Falls Knowledge
22. Do you believe that falls among people who have had a PFF surgery can be prevented?
 Yes
 No
For each of the next 13 questions, please rate how important each of these scenarios are in
making a person more likely to fall, whether they have had a PFF surgery or not.
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23. People are likely to fall because things such as rugs and furniture get in the way.
0

1

2

3

4

5

6

7

8

9

Not at all likely

10

Most likely

24. People are likely to fall because grab bars are not present or are not in a helpful position
in their house or apartment.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

25. People are likely to fall because sidewalks and streets are not clear of ice and snow.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

26. People are likely to fall because sidewalks and streets are poorly maintained (e.g. cracked
or irregular pavement).
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

27. People are likely to fall because handrails are not present or are poorly positioned in
public places.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

28. People are likely to fall because they have a coordination or balance problem.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

29. People are likely to fall because they do not have enough muscle strength or endurance in
their legs.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

30. People are likely to fall because their bones are weakened with age (osteoporosis).
0

1

2

Not at all likely

3

4

5

6

7

8

9

10

Most likely
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31. People are likely to fall because they have poor vision.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

32. People are likely to fall because they do unsafe or risky things.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

33. People are likely to fall because they do not always pay close attention to their
surroundings.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

34. People are likely to fall because they are forgetful.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

35. People are likely to fall because they take many medications.
0

1

2

3

4

5

6

7

8

Not at all likely

9

10

Most likely

36. On a scale from 0 to 10, where 0 means “not at all important” and 10 means “most
important”, how important is falling compared with your other health concerns?
0

1

2

3

4

5

Not at all important

6

7

8

9

10

Most important

37. Do you feel unsteady when walking?
 Yes
 No
38. Do you think you will fall at some time in the next 12 months?
 Yes
 No
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39. If you fell and seriously injured yourself (defined as injury such as fracture, dislocation,
head trauma that required medical attention), do you think you would be able to return to
your current living situation?
Strongly agree

Agree

Undecided

Disagree

Strongly disagree

40. After your PFF surgery, do you remember being taught by any health care professionals
about strategies to prevent falls after the surgery?
 Yes
 No
41. Please describe any things you have modified in your daily activities and/or home to
reduce the risk of falling since having your PFF surgery.
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

42. Please list any things that you plan to modify in your daily activities and/or home to
reduce
the risk of falling
____________________________________________________________________________
____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
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43. Do you feel confident you will be able to make the changes you have listed in question
#42?
 Yes
 No
44. Is there something that might make it difficult for you to do the changes you listed in
question #42 are?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
45. I am very keen to lower my risk of falling by using the strategies I listed in question #42.
Strongly agree

Agree

Undecided

Disagree

Strongly disagree

46. I am interested in learning more about how to prevent falls.
Strongly agree

Agree

Undecided

Disagree

Strongly disagree

Psychological Outcome Measures:
GDS-SF Score:

___________________ Date Completed: _____/ _____/________

WHOQOL-BREF Score:

___________________ Date Completed: _____/ _____/________

47. Do you feel socially isolated after the PFF surgery?
 Yes
 No
48. Do you feel frustrated with your current situation?
 Yes
 No
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49. How has PFF surgery impacted your life psychologically?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________

Version Date: 19th July 2019
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